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ABSTRACT
Free radicals, the highly reactive, unstable molecular species implicated in the development of 
many diseases, are introduced and the analytical methods available for their estimation reviev^ed. 
One approach, the measurement of the aspirin metabolites salicylic acid (SA) and 2,3- and 2,5- 
dihydroxybenzoic acid (DHBA) is fully examined.
The improvement and validation of a method for the routine measurement of SA in-patients 
receiving prophylactic doses of aspirin resulted in an assay with the following characteristics
0.5ml serum, acidified to pH 2.5, and applied to a HAX™ (Jones Chromatography) mixed phase 
SPE column preparation in succession with methanol and pH 2.5 acetate buffer. After further 
buffer washes, the SA was eluted with methanol containing 3%NHs (v/v). The dried extract was 
reconstituted in 500 j l i 1 HCl (0.05M).
HPLC separation, free from interference, was achieved on a 250 x 4.6 mm Cis column of 5fi 
particle size, at a temperature of 30°C, using a mobile phase of 30mM citrate buffer pH 4.75 
containing 28.6% (v/v) methanol flowing at l.Oml/min. The electrochemical detector (Antec Ltd) 
oxidising potential was set at 1.1 OV.
Mean SA extraction efficiencies were 85% over a 0.1 - 50jaM linear range. The internal standard, 
4- methylsalicylic acid (4-MeSA), was selected from a number of candidates, based on 
chromatographic, voltammetric and extraction characteristics. Intra-assay precision was 7.1, 6.2 
and 4.6% (CV, n = 9), at 1.5, 15 and 35|liM respectively; inter-assay precision was 16,9, 8.5 and 
6.6% (CV, n = 9) at 1.5, 15 and 35j.iM respectively. SA was stable for 13 days in water, 
hydrochloric acid and serum at pH 7.3 - 7.5 and pFI 2.5 at -30°C, 4°C and room temperature.
Development of an assay for 2,3-DHBA and 2,5-DHBA was only partially completed as described 
below:-
2,3-DHBA and 2,5-DHBA were also extracted by SPE as described above. Chromatography took 
place on a similar Cig colunm at 30*^0 at a flow rate of l.Oml/min. Successful resolution of 
analytes, IS and unknown extracted peaks was obtained using 30mM citrate buffer containing no 
methanol, by modification of the pH to 5.3. However, a gradient of increasing methanol 
concentration was added to elute the polar compounds and shorten run times. An optimum 
oxidation potential of 0.75V was required for the detection of 2,3- and 2,5-DHBA making the 
selection of a new IS, 3,4-DHBA, with a similar voltammogi am, necessaiy.
Preliminary extraction efficiencies for 2,3- and 2,5-DHBA at a concentration of lOOnM were 
found to be 79% and 73% respectively. 2,3- and 2,5-DHBA were found to be stable for up to 2.5 
hours in aqueous solution at room temperature. Both analytes are therefore less stable than SA. 
Precision data are required to complete the validation of this assay.
Clinical application of the SA method was carried out using blood from 8 diabetic patients Icnown 
to be taking low doses of aspirin. SA was detected in all specimens, with levels of SA ranging 
from 0.23 - 10.51|iM after administration of low-doses of aspirin from 75 - 300mg/day.
Blank serum samples from subjects known not to have taken aspirin were analysed for SA (n = 6) 
and 2,3 and 2,5-DHBA (n = 11) by the methods described above. Unexpectedly, SA was detected 
in all samples in the range 15 - 75pmol/ml. Similarly, peaks with the same retention time as 2,3- 
and 2,5-DHBA were found in all samples. The presence of all three analytes was confirmed by 
voltammetric comparison with standard solutions. The origin of these analytes in samples from
control subjects is known, but since SA, 2,3- and 2,5-DHBA have been detected in a number of 
different foodstuffs, a dietaiy source should be considered.
With little further development, the methods described above are sufficiently sensitive, robust and 
reliable for use in measuring the extent of free radical involvement in various disease states by 
assaying relative levels of these analytes following low-dose aspirin administration.
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INTRODUCTION
1. ACETYLSALICYLIC ACID (ASA)
1.1 Background
In a letter to the Right Honourable George, Earl of Macclesfield, president of the Royal Society, 
April 25th, 1763 the Rev Mr. Edmund Stone wrote,
"There is a bark of an English tree, which I have found by experience to be a powerful astringent, 
and veiy efficacious in curing anguish and intermitting disorders."
What Stone had actually discovered was a gioup of compounds known as the salicylates. The bark 
of the willow tree (Sa/ix alba) is astringent because it contains high levels of salicin, the glycoside 
of salicylic acid. Half a centuiy later French and German chemists competed to find the active 
ingredient of the willow bark. Not until 1838 did Raffaele Piria of Pisa, working in Paris, give the 
compound the name by which it is known today: salicylic acid (SA).
Acetylsalicylic acid commonly known as ‘Aspirin’ (Fig la, p .l) was not discovered until 1898 at 
the Bayer division of I.G. Farben. The new drug substance was named aspirin, the "a" from acetyl 
and the "spirin" from the German Spirsaure (the French root would have yielded asalicylin).^
FigM
COOH
OCOCH3
Acetylsalicylic acid 
(ASA)
COOH
Salicylic acid 
(SA)
SA (Fig lb, p i) is the primaiy metabolite of aspirin and great interest has been shown in this drug 
and its metabolite for almost 100 years. Aspirin is widely used as an over the counter and 
prescription drug for treating many conditions. Its mechanism of action, to some extent, still 
remains a subject of dispute, particularly because it has a multiplicity of actions both central and 
peripheral. Its convenience as a research tool is unquestioned in that it is a representative organic 
acid that can be isolated easily and deteeted with great sensitivity by chromatographic means, is of 
low toxicity suitable for human consumption and exliibits a variety of different metabolic 
pathways.
1.2 ChemistiT and stability
Aspirin is a non-steroidal anti-inflammatoiy drug (NSAID). It is the salicylate ester of acetic acid 
and has a chemical formula CgHgO  ^with a molecular weight of 180.2. In vivo, the drug rapidly 
hydrolyses to salicylate and acetate. Aspirin occurs as colourless or white ciystals that are usually 
tubular or needle-like, or as a white ciystalline powder and may have a faint odour. Its solubility in 
different solutions is: 1 in 300 of water; 1 in 6 of alcohol; 1 in 17 of chloroform and 1 in 15 of 
ether. It is soluble in solutions of acetate and citrates and decomposes in solutions of alkali 
hydroxides and carbonates.
Aspirin is stable in diy air, but in moist air or in aqueous or alcoholic solutions the drug gradually 
hydrolyses to salicylate and acetate and emits a strong vinegar like odour. The rate of hydrolysis is 
increased by heat and is pH dependent.
In aqueous solutions aspirin is most stable at pH of 2-3, less stable at a pH of 4-8 and least stable 
at a pH less than 2 or greater than 8. In a saturated aqueous solution at a pH of 5-7, aspirin is 
almost completely hydrolysed within one week at 25°C. ^
1.3 Pharmacology
Aspirin is used for its antithrombotic, antipyretic and antirheumatic effects. Although aspirin 
hydrolyses to salicylate and acetate, the drug does not require hydrolysis to produce its effects and 
appears to have some pharmacological effects that are distinct from those of the salicylates. The 
ability of aspirin to acetylate proteins e.g. platelet proteins, results in some inhibition of platelet 
aggregation, which other currently available salicylates do not exliibit.
In terms of haematological effects, aspirin inhibits platelet aggregation induced by epinephrine or 
low concentrations of collagen but not that induced by thrombin or high concentrations of 
collagen.^ Aspirin inhibits the second phase of platelet aggregation by preventing release of 
adenosine diphosphate (ADP).
Like the analgesic and anti-inflammatoiy effects, the effects of aspirin on platelets appear to be 
mainly associated with inhibition of prostaglandin synthesis.^ Aspirin irreversibly acetylates and 
inactivates cyclo-oxygenase in circulating platelets and has been extensively investigated for 
potential therapeutic effects in the prevention of thrombosis, particularly ai terial thrombosis.'^ This 
inactivation prevents platelet synthesis of prostaglandin endoperoxides and thromboxane A ,^ 
compounds which induce platelet aggregation and constrict arterial smooth muscle. Since cyclo- 
oxygenase in platelets is not resynthesized, this effect of aspirin on platelet function persists for 
the lifespan of platelets (4-7 days).
1.4 Pharmacokinetics
Approximately 80-100% of an oral dose of aspirin is absorbed from the gastro-intestinal tract. 
However, the actual bioavailability as unhydrolysed aspirin is lower since aspirin is partially 
hydrolysed in the gastro-intestinal mucosa to SA during absorption and on first passing through 
the liver.^
The rate of absorption of aspirin depends on various factors, including the dosage form, with 
aqueous solutions being most rapidly absorbed. Following oral administration of single doses of 
rapidly absorbed aspirin dosage forms, salicylate is detected in serum within 5-30 minutes and 
peak serum salicylate concentrations are attained within 0.25-2 hours. In vitro dissolution of film 
coated tablets does not differ from that of uncoated plain tablets, but the film coated tablets do not 
undergo dissolution in the mouth during administration.'*’^
1.5 Disposition in the body
Aspirin is rapidly and widely distributed into most body tissues and fluids."  ^The volume of 
distribution of aspirin and SA is about 0.15 litres/kg of body weight. Aspirin is poorly bound to 
plasma proteins with only one third of the unhydrolysed form of the drug bound in serum at a 
salicylate concentration of 120ug/ml.
1.6 Uses of ASA
Aspirin is used acutely for its analgesic, antipyretic and anti-inflammatoiy effects as well as in 
prevention of myocardial infarction (MI) and stroke. The principal adverse effects associated with 
aspirin are gastro-intestinal, but other side effects do exist. Aspirin is used to a veiy limited extent 
in children because of the risk of Reye's syndrome.
Aspirin has been used extensively in the treatment of coronaiy arteiy disease where it has been 
found to reduce the risk of death or non-fatal recurrent MI in patients surviving an MI, although 
the precise value and optimal dosage and timing of prophylactic aspirin therapy in these patients 
remains to be fully elucidated.’’***
The report of the 'Physicians Health Study''* suggests that aspirin therapy of 325mg once eveiy 
other day can reduce the overall risk of MI, both non-fatal and fatal, by 50% in men.
2. FREE RADICAL THEORY
2.1 Free radicals. What are they?
A free radical is any species capable of independent existence that contains one or more unpaired 
elections, an unpaired electron being one that is alone in an orbital.*^ Free radicals are extremely 
reactive species with rate constants of the order of 10  ^-10*** M'*s’*, their reactivity due to the 
unpaired electron in an outer orbital. Since these radical reactions proceed so rapidly, special 
techniques are required to measure their rates.
Pulse radiolysis is one of these techniques and involves placing a solution of the compound in a 
reaction cell and pulsing the solution with ionising radiation from a linear accelerator. Specific 
radicals can be generated and their reactions followed by change in light absorption of the cell 
components on an oscilloscope.
The most important free radical reactions take place in vivo in the form of univalent biochemical 
redox reactions with oxygen being the main component of most free radical species.
The term "reactive oxygen species" (ROS) is a collective one that not only includes species such 
as hydroxyl and superoxide radicals, but also some non-radical derivatives which are nonetheless 
veiy important in free radical activity such as hydrogen peroxide and hypochlorous acid.
2.2 Hydroxyl free radical production
Hydroxyl free radicals are produced in two main ways: reaction of transition metal ions with 
hydrogen peroxide; and homolytic fission of water caused by background exposure to ionising 
radiation.
2.2.1 Fenton chemistiT
Transition metal ions in the first row of the d-block in the periodic table have impaired electrons 
with the exception of zinc. However, copper does not readily fit the definition of a transition metal 
since the d orbital is full but it can readily lose two electrons to form Cu^^, one from the 4s and one 
from the 3d orbital. An important feature of transition metals is their variable valence states which 
allows changes in oxidation state involving one electron. This is crucial in their role in free radical 
production.
In 1894 Fenton obseiwed that a mixture of hydrogen peroxide and Fe(II) salts reacted with many 
biological molecules and that the reactivity was probably due to the reactivity of the hydroxyl 
radical. This reaction is known as the Fenton reaction (See eq" 1)
Fe’" + H2O2 — > Fe^  ^ + HO' + HO: (eq" 1)
*Oxygen itself is a diradical (2 unpaired electrons in 71 2p antibonding molecular orbital) and
univalent reduction of this molecule produces the superoxide radical (1 paired and 1 unpaired
*electron in 7t 2p antibonding molecular orbital). In an aqueous environment this superoxide
*radical can react to form hydrogen peroxide (both 7t 2p antibonding m olecular orbitals are filled).
Hydrogen peroxide itself is not a free radical but in the presence of Fe(II), Fenton reactions occur. 
A Fenton reaction occurs when hydrogen peroxide reacts not only with ferrous iron [Fe(ll)] but 
also with other transition metals such as copper. The resulting ferric iron (Fe^^) can then be 
reduced, by reducing agents such as ascorbate, in the presence of superoxide to recycle ferrous 
iron (Fe’ )^ and a chain reaction is set up. (See eq" 2)
Fe^ + 4- O2 ' —-> Fe^" + O2 (eq  ^2)
Iron and copper are available in vivo and are capable of catalysing radical reactions but organisms 
take great care in the handling of iron using both transport (transferrin) and storage (ferritin and 
haemosiderin) proteins therefore minimising the amount of free iron within cells and extracellular 
fluids. Iron is released from proteins (haemoglobin, myoglobin) at low pH after damage by 
peroxides by reductive mobilisation involving a superoxide radical.*^
2.2.2 Ionising radiation
The other main way in which hydroxyl radicals are produced is by ionising radiation. The main 
component of all living cells is water and exposure of cells to ionising radiation such as X-rays or 
y-rays ultimately leads to the production of hydroxyl free radicals. In contrast, ultraviolet (UV) 
radiation does not have sufficient energy to ionise water molecules but has sufficient energy to 
generate hydroxyl radicals by the homolytic fission of hydrogen peroxide.
One of the most susceptible targets for hydroxyl free radical attack is cellular deoxyribonucleic 
acid (DNA). This causes the formation of double strand breaks which cannot be repaired by the 
cell. Oxygen enhances the damage caused by ionising radiation tlirough the generation of 
superoxide radicals thus leading to the production of more hydroxyl radicals.*'* However, the 
knowledge of the mechanisms of damage to DNA by free radicals may be of therapeutic benefit in 
the killing of tumour cells.
2.3 Free radical measurement
The veiy high reactivity of radical species makes direct measurement of free radicals in vivo 
extremely difficult. Many of the methods that have been developed are based on measuring the 
extent of damage a free radical causes to endogenous macromolecules such as lipids, proteins, 
carbohydrates and DNA.
2.3.1 Electron spin resonance (ESR)
ESR is considered to be the 'gold standard' technique in the identification of free radicals but 
unfortunately this technique has a veiy limited place in the analysis of samples from patients. The 
toxic nature of the spin traps does not permit administration to humans for studies in vivo}^
2.3.2 Lipid peroxidation
Polyunsaturated fatty acids are especially susceptible to attack by free radicals. Those incorporated 
into lipids are readily attacked by free radicals becoming oxidised into lipid peroxides.'**
Lipid peroxidation is initiated by attack on a fatty acid or a fatty acyl side chain by any chemical 
species that has sufficient reactivity to abstract a hydrogen atom from a methylene carbon in the 
side chain. The greater the number of double bonds present the more susceptible and therefore the 
easier it is to abstract the hydrogen from the methylene carbon. Polyunsaturated fats are 
particularly susceptible to attack due to the high number of double bonds present. The resulting 
carbon centred radical can have several fates, but in the presence of oxygen it forms a peroxyl 
radical. Peroxyl radicals can attack fatty acid side chains, removing hydrogen and so propagating 
the chain reaction known as lipid peroxidation (Fig 2, p.9).
Lipid peroxide measurement is the most widely used measurement of the rate of peroxidation of 
membrane lipids or fatty acids. At each intermediate stage in the lipid peroxidation process 
different compounds are formed. Individual techniques have been used to detect these compounds 
but no one method by itself can be said to be an accurate measure of lipid peroxidation.
Fig. 2 Proposed mechanism for the formation of lipid hydroperoxides and cyclic peroxides from 
arachidonic acid. Initial abstraction of H at C-13 is shown. H can also be abstracted at 
C-10 or C-7, giving several other peroxide end products.
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2.3.3 Thiobarbituric acid (TBA) test
The TEA test is by far the most commonly used assay because of its simplicity and cheapness. 
The sample under investigation is heated at acid pH with TEA to produce a pink chromagen 
([TEA]2-malondialdehyde). This absorbs at a wavelength of about 532nm and fluoresces at 
553nni. This test measures the amount of malondialdehyde (MDA) present at the end of the 
peroxidation process.
The first biological use of the TEA reaction was in 1944 where it was observed that brain tissue 
incubated in the presence of oxygen gave a colour with 2-thiobarbituric acid.'^
Colorimetric assays have been shown to have low specificity and more recently fluorimetric 
assays have become more popular due to better specificity and sensitivity obtained. Extraction of 
the coloured product into n-butanol iismg spectrofluorimetric detection (Excitation wavelength 
532nm, emission wavelength 553nm) has provided better results.
Various high performance liquid chromatography (HPLC) methods have been introduced to 
improve specificity, but the problem with HPLC methods still lies in the variation in reference 
ranges from laboratoiy to laboratoiy depending on which TEA test is employed.
The TEA test works well when applied to specific biological matrices but its application to body 
fluids and tissue extracts has produced a number of problems.
2.3.4 Peroxide measurement
Measurement of peroxides can be demonstrated using a variety of different techniques, 
lodometric measurement can be used for measuring lipid peroxides. The lipid peroxides produced 
are capable of oxidising iodide (T) ions to iodine (E) which can be estimated by titration with 
sodium thiosulphate.^^ Glutathione peroxidase reacts with hydrogen peroxide and fatty acid 
hydroperoxides simultaneously oxidising glutathione (GSH) to its oxidised form.^^ Gas 
clnomatography mass spectrometry (GC/MS) has been used to measure both lipid peroxide 
products and aldehydes.
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2.3.5 Conjugated clieiies
Conjugated dienes are formed by the peroxidation of unsaturated fatty acids and absorb UV light 
in the range 215-250mn. Conjugated diene measurement is a useful measure of the damage caused 
in the early stages of the peroxidation process. HPLC has been used to separate conjugated dienes 
and it was reported that one intermediate product formed was an isomer of linoleic acid, octadeca- 
9(cis),ll(trans)-dienoic acid. '^* However, this isomer was later identified as resulting from 
bacterial fatty acid metabolism.^^ Conjugated dienes can be found in the diet of animals. This 
results in background levels and provides a problem when quantifying the degree of tissue damage 
in cu rred .T h e  main difficulty with diene conjugate measurement in biological materials is the 
high background absorption at 230nm to 235nm due to polyunsaturated fatty acids and breakdown 
products of lipid peroxides as well as haem proteins, purines and pyrimidines. Improved resolution 
of the conjugated diene peak using second derivative spectroscopy has been achieved.^’
2.3.6 Hydrocarbon gas measurement
The hydrocarbon gases pentane and ethane can be measured during the decomposition of lipid 
peroxides. These gases can be measured using GC/MS, but only small amounts are produced.^®
Diene conjugation and direct measurement of lipid peroxides tell us about damage caused in the 
early stages of the lipid peroxidation process, whereas measurement of aldehydes and hydrocarbon 
gases highlight the damage caused towards the end of lipid peroxidation. The method to use will 
depend at which stage in the peroxidation process is required to be looked at. hi many cases it will 
be advisable to use more than one method due to the non-specific nature and potential problems 
associated with these methods.
Free radicals not only cause damage to lipids but can also attack proteins, carbohydrates and 
DNA.
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2.3.7 Protein oxidation
Protein oxidation involves the free radical attack of aromatic amino acids, cysteine and disulphide 
bonds and to a lesser extent proline residues. The characteristic feature of free radical reactions 
involving proteins is the induction of autofluorescence with excitation and emission maxima in the 
region of 360nm and 460nm respectively.
2.3.8 Carbohydrate oxidation
It is well documented that simple monosaccharides autoxidise under physiological conditions 
generating superoxlde^\ The formation of this superoxide on the protein backbone, in close 
association with aromatic amino acids enhances the oxidation and crosslinking of such proteins.
2.3.9 DNA oxidation
DNA is an important cellular target for free radical attack in vivo. Attack of the hydroxyl radical 
on DNA produces a large number of different chemical species. Oxygen free radicals can induce 
damage to DNA yielding strand breaks and include conversion of thymine into thymine glycol and 
5-hydroxymethyluracil, and of guanine residues into 8-hydroxyguanine. DNA repair systems 
involved in repairing attack by oxygen/hydroxyl radicals act by an excision repair system. In its 
simplest form a damaged part of the DNA strand is removed, new DNA synthesis fills the gap and 
finally a DNA ligase enzyme joins the newly synthesised DNA to the rest of the strand.
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2.4 Aromatic hydroxylation
A knowledge of the oxidation of aromatic compounds by metal ion/hydrogen peroxide complexes 
has existed for over 80 years.
In order that in vivo studies can be carried out it is necessary that the aromatic compounds 
involved have a sufficiently high concentration to compete with other scavenger molecules and the 
products of hydroxylation do not react further or form enzyme mediated products.®^
At low pH, in the absence of oxidising metal ions, benzoic acids favour decarboxylation reactions. 
In the case of SA, catechol is formed. Under physiological conditions (pH 7.4, metal ions and 
oxygen present), hydroxylation is the predominant reaction observed.
The hydroxylation of aromatic compounds takes place in a systematic way with the attachment of 
the polar hydroxyl radical to each ring position dependent on the electron donating/withdrawing 
properties of the substituent attached to the ring. Raghaven and Steenken demonstrated that the 
fractions of hydroxyl attack at the ipso, ortho, meta & para positions of phenol are 0.08, 0.48, 0.08 
and 0.36 respectively.^® Electrophilic reaction of the hydroxyl radical with phenol shows a strong 
preference for attack at the ring positions activated by the phenolic hydroxyl group i.e. ortho & 
para positions.®'^
Aromatic hydroxylation assays were first introduced into biological systems by Halliwell®® using 
the xanthine/xanthine oxidase system as the source of hydroxyl radicals and salicylate as the 
aromatic detector molecule.
Hydroxylation of benzene occurs®*’ but it is the hydroxylation of aromatic derivatives of benzene 
which have been studied more fully. Tlnee aromatic compounds that have been used are phenol, 
phenylalanine and SA, with anisole and aniline used to a lesser extent,®  ^ These have been shown 
to hydroxy late in a similar manner to that of phenol.
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2.4.1 Phenol hydroxylation
Raghaven and Steenken investigated the mechanism of attack of hydroxyl radicals on phenol (As 
above, p.13). From this in vitro study they found that 4 intermediate dihydroxycyclohexadienyl 
radicals were formed giving four possible hydroxyl products after oxidation. In this instance 
catechol and hydroquinone (1,2 & 1,4-dihydroxybenzene respectively) were preferentially formed. 
An in vitro study by Floyd et al produced similar findings for phenol with undetectable amounts of 
resorcinol (1,3-dihydroxybenzene) detected. Raghaven and Steenken used pulse radiolysis with 
optical detection, whereas Floyd et al used three different hydroxyl-generating systems: 
ADP/Fe(n)/H202,; hypoxanthine/xanthine oxidase; and UV photolysis of water. FIPLC with 
electrochemical detection (BCD) was used to detect the hydroxylated products in the Floyd 
method.
2.4.2 Phenylalanine hydroxylation
When the essential amino acid phenylalanine is administered to humans the enzyme L- 
phenylalanine hydroxylase converts it into L-^-tyrosine. However, if a hydroxyl radical attacks the 
D- or L- phenylalanine then three isomers o/Y/zo-tyrosine, wzeto-tyrosine and /jczra-tyrosine are 
produced. This was shown in viti'o (ozonised aqueous solutions) and in vivo by showing that blood 
from premature babies appears to be capable of catalysing hydroxyl radical formation via Fenton 
reactions involving iron.®^
2.4.3 Salicylate hydroxylation
A lot of interest has been shown in salicylate hydroxylation since aspirin is a widely used 
medication and is rapidly hydrolysed to SA with further metabolites being produced (Fig 3, p. 15).
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Fig. 3 Main enzymatic and oxidative by-products of human aspirin metabolism
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The first work to be carried out using aspirin and hence SA for hydroxyl radical detection in vivo 
was by Halliwell et al?^ Floyd et al used the same three hydroxyl generating systems in vitro as 
used when investigating the hydroxylation of phenol to see if SA would behave in a similar 
manner, and confirmed that 2,3-dihydroxybenzoic acid (2,3-DHBA) and 2,5-dihydroxybenzoic 
acid (2,5-DHBA) were predominantly formed/^
Ingelman-Sundberg et al later demonstrated that although 2,5-DHBA is formed by hydroxyl free 
radical attack on SA, microsomal fractions from mammals treated with inducers of cytochrome P- 
450 also produce 2,5-DHBA. However, 2,3-DHBA formed under the same conditions occurred 
only by the primaiy reaction of hydroxyl free radicals with SA.
2.5 Antioxidants
An antioxidant is any compound that, when present in low concentrations compared to those of an 
oxidisable substrate, significantly delays or inhibits oxidation of that substrate.
Antioxidants can be divided into two main classes; chain-breaking antioxidants and preventive 
antioxidants.
Chain-breaking antioxidants react with radicals to produce a relatively stable antioxidant radical 
compound causing chain reaction breakdown. Preventive antioxidants rapidly scavenge active 
species before they can interact with susceptible targets. These are simplified definitions as many 
antioxidants have several mechanisms of action.
Many of the non-enzyme antioxidants exist in extracellular fluids, a-tocopherol, a chain breaking 
antioxidant, delays lipid peroxidation by scavenging intermediate products. However, chain 
breaking antioxidants such as a-tocopherol, can have a pro-oxidant effect towards non-lipids 
under certain conditions often because they can bind Fe(IH) ions and reduce them to Fe(Il), hence 
a catalytic Fenton reaction can take place. In most extracellular fluids the major defence against 
oxidants may be to prevent metal ions from participating in radical reactions.
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Uric acid, albumin, haptoglobin, and hemopexin have been shown to inhibit various free radical 
reactions by acting in this m a n n e r Ceruloplasmin, an important extracellular antioxidant, 
oxidises Fe^ '*' to Fe^\ which swiftly binds to transferrin, as will any iron mobilised from serum 
ferritin.
The food industry relies heavily on chain-breaking antioxidants including butylated 
hydroxyanisole (BHA) and butylated hydroxytoluene (BUT). These protect food lipids in a similar 
manner to the way a-tocopherols do in lipid peroxidation.
Many plant phenolics have been described as antioxidants since they inhibit lipid peroxidation but 
they can also accelerate oxidative damage to non-lipid biomolecules such as DNA. This occurs by 
the reduction of Fe^  ^ to Fe^  ^or by oxidation to produce superoxide and hydrogen peroxide. 
Enzyme antioxidants that exist in vivo occur intracellularly as preventive antioxidants. Superoxide 
dismutase (SOD) is a preventive antioxidant that rapidly converts superoxides to hydrogen 
peroxide. The hydrogen peroxide produced can then interact with catalase, another preventive 
antioxidant. Haemoglobin and myoglobin can convert hydrogen peroxide to water and oxygen and 
work most effectively in the presence of reducing agents such as ascorbate. In the absence of a 
reducing agent free iron may eventually be released.
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3. ANALYTICAL METHOD REVIEW
3.1 Review of analytical methods available for measurement of Salicylic acid (SA ) in serum 
plasma and urine.
SA is commonly administered in its acetylated form as aspirin and can be measured after the 
administration of low doses of aspirin (typically <300mg). This requires highly sensitive and 
specific methods. Many different techniques have been employed for the measurement of SA in 
serum, plasma and urine, however, most of these methods lack the required sensitivity to measure 
SA in patients administered with low doses of aspirin. A review of different analytical techniques 
used for measuring SA is provided in a paper by Stewart and Watson where UV, fluorimetric, 
colorimetric, chromatographic, immunoassay and enzymatic methods are discussed.'*^
Gas chromatography (GC) techniques have been used for detecting SA but in many cases are not 
the method of choice as they require complex derivatisation procedures which are time 
consuming, impractical and unattractive for routine use in many laboratories. Pederson and 
Fitzgerald developed a GC/MS method using a stable isotope dilution assay which detects both 
labelled and unlabelled aspirin and SA in plasma following co-administration experiments.'''^ This 
produced sensitive and specific results, with a limit of detection of 72pmol/ml (lOng/ml), but 
involves complex deuterium labelling experimental preparation.
HPLC has proved the most convenient chromatographic tool for routine analysis of SA. HPLC 
with UV detection has been widely used and is suitable for toxicological purposes where low 
sensitivity is not required. In the paper by Shen et al they use an ion-pair HPLC method with 
UV detection at 229nm. Extraction recoveries of 92-100% and coefficient of variation (CV) of 
less than 10% at 72, 720 and 7200nmol/mL (n=6) were achieved, however, the limit of detection 
(LOD) was 720pmol/ml, indicating that this was a relatively insensitive method.
Fung and Luk reported a method for the determination of SA in various pharmaceutical 
formulations and foods by differential-pulse voltanunetiy using a glassy carbon electrode.''^
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Hassan and Hamada have also reported a selective determination of salicylate in pharmaceutical 
formulations using a liquid membrane electrode.''^
To date, there are few reports on the use of amperometric detection of SA from biological 
matrices. Selinger and Purdy reported the determination of SA and its metabolites in blood plasma 
by HPLC with amperometric detection and back-extraction, giving limits of detection for SA in 
the submicromolar range.'*  ^Evans et al investigated the oxidation of SA at a planar glassy carbon 
electrode and showed that the electrode reaction was found to be dependent on the pH and the 
ionic strength of the acetate buffer, which contained 35% methanol. The average extraction 
recoveiy from serum was about 60% with an CV of 5.8%.'*^
Of the methods described above for measuring SA, many use a liquid-liquid extraction process 
using HPLC with UV or fluorescence detection which are relatively insensitive. Very few papers 
describe methods involving ECD. Liquid chromatography-electrochemistry has proven to be a 
viable tool for solving a wide variety of analytical problems, primarily in biomedical research and 
one of the main aims of this thesis was to develop a sensitive and robust method for the 
determination of SA in serum at levels equivalent to those of patients taking low doses of aspirin.
3.2 Review of analytical methods available for the estimation of 2.3-dilivdroxvbeiizoic acid 
(2,3-DHBA) and 2,5-dihydi oxybenzoic acid (2,5-DHBA) in serum plasma and urine.
Measurement of free radicals in vivo is difficult due to their high reactivity. In order to estimate 
the damage caused by free radicals, secondary products such as aromatic hydroxylation products 
can be quantified directly by chromatographic techniques. Two such compounds that are formed 
as a result of the hydroxyl radical attack of SA are 2,3-DHBA and 2,5-DHBA.
Aromatic hydroxylation assays were first used in 1978 using colorimetric techniques'^ but HPLC 
methods using both UV and EC detection are now preferred due to their enhanced specificity and 
sensitivity.
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Grootveld and Halliwell investigated aromatic hydroxylation as a potential measure of hydroxyl 
radical attack using SA as the aromatic scavenger molecule. They proposed that conversion of SA 
or other aromatic compounds into specifically hydroxylated products would be a useful marker of 
hydroxyl free radical attack.^® Grootveld and Halliwell later showed that 2,3-DHBA was a product 
of human aspirin metabolism using HPLC with ECD and mass spectrometry (MS) to identify the 
2,3-DHBA. They found it to be present in low concentrations in comparison with other 
metabolites that were produced.^'
Work carried out by Ingelman-Sundberg et al confirmed that 2,3-DHBA was not formed by the 
catalytic hydroxylation of microsomal P-450 but that its conformational isomer 2,5-DHBA was 
produced.H ence, measurement of 2,3-DHBA and not 2,5-DHBA could provide a means of 
monitoring hydroxyl radical attack. Following on from the work carried out by Ingelman - 
Sundberg, Halliwell et al highlighted the above findings in a paper entitled ‘A short cautionaiy 
note’^^
Floyd et al suggested that formation of both 2,3-DFIBA and 2,5-DHBA maybe a way of 
determining hydroxyl radical activity in biological systems. Detection and quantitation of the 
hydroxylation products obtained and formed during hydroxyl radical generation had been 
demonstrated in “biologically meaningful systems”. The three systems utilised were 
ADP/Fe(H)/H202, hypoxanthine/xanthine oxidase plus chelated iron and UV photolysis of 
hydrogen peroxide. ECD was carried out at 0.80V for 2,3-DHBA and 2,5-DHBA but baseline 
resolution was not achieved in standard solutions. No extraction from biological matrices was 
carried out to demonstrate the absence of interference from other extracting compounds.
While the above method did not involve extraction from a biological matrix such as serum, plasma 
or urine, Grootveld and Halliwell discussed the potential measure of aromatic hydroxylation 
products in v/vo.^° They found that attack by hydroxyl radicals, generated by a Fenton system, 
upon SA produced 2,3-DHBA and 2,5-DHBA as the major products. HPLC with
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Fig. 4 Chromatograms showing separation of an extract from (a) plasma and (b) rheumatoid 
plasma from healthy volunteers taking aspirin (from Grootveld paper - see Ref 50).
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ECD was used to identify and quantify 2,3-DHBA and 2,5-DHBA in human plasma and synovial 
fluid. Although in vivo measurement was carried out using a liquid-liquid exti’action 
process,baseline resolution was not achieved. Extracts from both plasma and synovial fluid show 
very busy chromatograms at an oxidation potential (Eqx) of 0.96V (Fig 4a&b, p.21).
In 1992 an Italian group carried out a study utilising salicylate hydroxylation as an early marker of 
in vivo oxidative stress in diabetic patients.^^ As well as using salicylate hydroxylation, they used 
the TBA reaction in parallel and found that in diabetic patients higher levels of 2,3-DHBA were 
found, but that the TBA values between the two groups were veiy similar. Their results suggested 
that it might be useful to reveal in vivo oxidative stress independently from the peroxidation of 
lipids.
From a review of the of the work carried out on the detection of 2,3-DHBA and 2,5-DHBA from 
biological matrices, there has been a number of key validation parameters omitted including poor 
resolution of the analytes of interest and internal standard (IS) and no precision or stability work 
carried out on the analytes of interest or the IS. Of all the HPLC methods considered none have 
met the required sensitivity and specificity which are essential to permit determination of the 
metabolites of aspirin following the administration of low doses <300mg/day.
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4. ELECTROCHEMISTRY
4.1 Introduction to electrochemistry
Since 1974, when the first commercially available HPLC ECD was introduced, a considerable 
number of articles on design, performance and application have appeared in the scientific 
literature and today HPLC-ECD is widely accepted as a sensitive and selective technique for 
analysis of electroactive substances.
4.2 Theoiw of ECD
4.2.1 Detection principle
ECD of an analyte in the effluent of an HPLC-coluimi is based on electrochemical conversion 
(electrolysis) of the analyte at a measuring electrode, known as the working electrode ( WE), 
placed in the effluent stream. Electrolysis is activated by applying a voltage (potential) difference 
between the electrode and the mobile phase containing the analyte and results in electron transfer 
between electrode and analyte. The resulting "electron flow" (electrical current) is amplified and 
converted into a signal that we recognise as a peak in the chromatogram. Extremely small currents 
can be measured representing analyte quantities in the picogram region or less.
Electron transfer from the analyte to the WE is called oxidation (WE is the anode). Electron 
transfer from the WE to the analyte is called reduction (WE is cathode).
Oxidation of an analyte is favoured when the potential of the WE is made more positive; reduction 
is favoured when the potential is made more negative.
The WE potential is measured relative to a reference electrode, which has a fixed potential 
difference measured against the mobile phase.
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14.2.2 The three-electrode detection system |
Detector response is strongly influenced by voltage changes between the electrode and the mobile 
phase. A constant and known potential difference between the WE and the mobile phase is 
therefore a vital requirement to obtain stable, reproducible and predictable detector response.
A counter electrode, also known as the auxiliaiy electrode (AUX), is used to apply the potential 
difference between the mobile phase and the WE. This facilitates electrolysis of the analyte.
In principle, this two-electrode arrangement would be sufficient for electrolysis, however, due to 
"polarisation" processes in the electrode/mobile phase boundaiy layer and potential "drop" caused 
by electrical resistance of the mobile phase, the potential applied on the AUX versus WE may 
differ substantially from the potential of the mobile phase versus WE.
A stable and predictable potential difference between mobile phase and WE is therefore 
impossible with a two-electrode system. A third electrode known as the reference electrode (REF) 
is therefore required to monitor the potential of the mobile phase. Its potential versus mobile phase 
is constant and known, and is invariant with respect to mobile phase composition and current 
between the AUX and the WE.
4.2.3 Selecting a detector potential
To determine optimum WE-potential for a certain analysis we need to know how detector 
response (electrolysis current) is related to the WE-potential (voltage). Such a relationship (known 
diagrammatically as a voltamniogram) provides all the information necessaiy to determine the 
optimum detection potential for a certain analyte under given chromatographic conditions.
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4.2.4 Selectivity
Selective detection is based on the fact that different electroactive substances have maximum 
detector response at different potentials. Since the number of electroactive substances that can be 
electrolysed increases with increasing WE potential, optimum selectivity is obtained at minimum 
WE potential. The final choice for a detection potential usually is a compromise between 
sensitivity, stability of response and selectivity.
4.3 Electrode materials
4.3.1 WE material
The ideal WE should be electrochemically inert, able to be polished to minimise "internal pore 
surface", since internal pore surface contributes to noise (analyte molecules have no time to 
diffuse into the pores during passage along the WE surface), and is chemically inert.
Materials that match the above description are gold, platinum, gold/mercuiy amalgam, silver and 
carbon.
In the case of oxidative detection, carbon is the best choice in nearly all cases, therefore, glassy 
carbon (an amorphous glass-like carbon) is the standard WE material in most cells for HPLC-EC. 
Vitreous (glassy carbon) has been widely applied in electroanalytical work with, again, a good 
grade of glassy carbon being first choice for most oxidative applications. However, solid 
electrodes such as these are susceptible to adsorption^'* or surface fouling and surface oxidation. 
Fortunately a surface current can be identified since the peak height is directly proportional to the 
applied potential. The major practical problem of working solid electrodes is the maintenance of a 
uniform working electrode surface.
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4.3.2 Auxiliary electrode
The auxiliaiy electrode must be electrochemically and chemically inert and therefore carbon is the 
electrode material chosen. It has to be electrochemically inert in order to have a low signal/noise 
ratio and a constant baseline and chemically inert to prevent reaction with analytes which may be 
oxidised.
A certain knowledge of the principles of electrocheniistiy is therefore essential to enable optimum 
HPLC-ECD conditions to be created.
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5. SOLID PHASE EXTRACTION (SPE)
5.1 Background to SPE
SPE is a physical extraction process involving a liquid and a solid phase. Efficient extraction 
depends on the competing interactions between the isolate and the solvent the isolate is dissolved 
in, with the solid phase component of the column.
Over the past 20 years, SPE has become an important process in the preparation of biological 
specimens for routine analysis using different analytical techniques.
It wasn’t until the early 1970s that significant advances were made with the introduction of silica 
columns as the stationaiy phase. Small disposable columns containing silica, bonded silica and 
other bonded phases were later introduced.
5.2 Bonded silicas
The reaction of organosilanes with activated silica results in the formation of bonded silicas with 
the functional group of the organosilane attached to the silica substrate through a silyl ether 
linkage. In the case of large functional groups e.g. octadecylsilane (Cis) being attached there is 
steric hindrance and as a result there are a large number of unreacted silanol gi’oups (Si-OH) 
present which are free to undergo polar interactions. If these unreacted sites are not required a 
further reaction called endcapping can take place and this results in the formation of Si-CH] thus 
deactivating the silanol groups. The intent is to create a surface whose principal properties are due 
to the functional group allowing minimal interactions with the silica substrate. However, the 
process of endcapping only deactivates a maximum of 50% of the active silanol groups (Phase 
Separations seminar).
In practice, bonded silicas are stable within a pH range of 1-14 since degradation of the sorbent is 
a finite process and sorbents are exposed to solvents for only short periods of time.
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5.3 Selection of a suitable column
There are two different approaches for choosing a suitable sorbent. The sorbent can either retain 
the analyte of interest and release the unwanted components by the use of a suitable eluent. 
Otherwise, the sorbent can have a low affinity for the analyte and retain the unwanted 
components.
Both the nature of the sorbent and the sample therefore play important roles in the extraction 
process.
5.4 Interactions
The most common sorbent interactions can be grouped into one of four categories: non-polar, 
polar, ion-exchange, and covalent.
5.4.1 Non-polar interactions
Non-polar interactions occur between the carbon-hydrogen bonds of the sorbent functional group 
and the carbon-hydrogen bonds of the isolate. These forces are sometimes known as van der 
Waals or dispersion forces.
The most widely used sorbent for non-polar interactions is Cig. Since most organic molecules have 
some degree of non-polar character then non-polar interactions are not veiy selective.
5.4.2 Polar interactions
Polar interactions include hydrogen bonding, dipole-dipole and n-n in which distribution of 
electrons between individual atoms in the functional groups is unequal causing polarity. Some of 
the functional groups that display these type of interactions are hydroxyl, amines, carbonyls, 
aromatic rings and hetero atoms such as oxygen, nitrogen, sulphur and phosphorus.
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Due to the polar nature of the silica substrate (silanol gi'oups), polar interactions are characteristic 
of all bonded silicas. The interaction of these silanol groups are known as secondary interactions 
and are most significant in non-polar solvents.
5.4.3 Ionic interactions
Ionic interactions occur between the isolate molecules carrying a charge and a sorbent carrying an 
opposite charge to that of the isolate. Cationic (positively charged) examples include amines and 
inorganic cations such as calcium. Anionic (negatively charged) examples include carboxylic 
acids and phosphates.
For ion-exchange interactions to take place two criteria must be met:
1/ Both the isolate and sorbent have to be in a suitable pH environment to be charged.
2/ The solvent must not contain high concentrations of competing species.
It is, therefore, essential that pKa values of isolates are known.
5.4.4 Covalent interactions
Covalent interactions are those resulting in formation of covalent bonds between the sorbent and 
the isolate molecule. These interactions are designed to be reversible with a change to the solvent 
enviromnent. These sorbents are less commonly used but are highly selective.
Almost all available sorbents are capable of more than one type of interaction and this has to be 
taken into consideration when choosing a suitable column.
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5.5 Advantages of SPE over coiiveiitioiial extraction techniques
There are a number of advantages of using SPE over other more conventional types of extraction. 
High recovery of an analyte make an assay procedure more sensitive enabling a smaller sample 
volume to be used and quantified. The benefit of this is seen in studies where small sample 
volumes are required e.g. young children, neonates.
SPE manifolds are commercially available and can be used to reduce the time involved in carrying 
out an extraction procedure. This allows sampling of highly volatile or photosensitive analytes, 
hi addition to a reduction in time and labour, much less solvent is required for SPE extraction 
procedures in comparison to conventional techniques such as liquid-liquid extraction. This results 
in less waste disposal, fire hazard and generally benefits a safer working environment.
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6. Aims and obiectives of the current investigation
The main study aims at the outset of the work for this thesis were:-
1. To develop and improve on published methods the measurement of 2,3-DHBA, 2,5-DITBA and 
SA in human serum by utilising HPLC with BCD. The process of SPE would produce a "cleaner" 
extract thereby reducing chromatographic interference and allowing the tiiree analytes of interest 
to be separated.
2. To employ an appropriate IS to account for extraction losses.
3. To introduce autosampling and computerised data handling to facilitate a greater throughput of 
samples.
4. To confirm the identity of putative 2,3-DHBA, 2,5-DHBA and SA peaks through the use of 
alternative techniques such as GC/MS.
5. To validate the improved methods for measuring concentrations of 2,3-DHBA, 2,5-DHBA and 
SA by carrying out precision, accuracy, linearity, stability and recovery studies.
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EXPERIMENTAL
1. MATERIALS
1.1 Chemicals
P-resorcyclic acid (2,4-dihydroxybenzoic acid), gallic acid (3,4,5-trihydroxybenzoic acid), a- 
resorcyclic acid (3,5-dihydroxybenzoic acid), 3,4-dihydroxbenzoic acid,//-hydroxybenzoic acid 
(4-hydroxybenzoic acid), isovanillic acid (3-hydroxy-4-methoxybenzoic acid), 4-methylsalicylic 
acid, 3-methylsalicylic acid (Sigma Chem.Co.); w-anisic acid (3-methoxybenzoic acid), m~ 
hydroxybenzoic acid (3- hydroxybenzoic acid), 2,3-dimethoxybenzoic acid, 3-metlioxysalicylic 
acid, 2- bromobenzoic acid, 2-iodobenzoic acid, 2-chlorobenzoic acid, 3-fluorobenzoic acid, 2,5- 
dihyroxyphenylacetic acid gamma-lactone, 2,5-dilidroxyphenylacetic acid, 3-hydroxy-4- 
methylbenzoic acid, 2-hydroxy-3-isopropylbenzoic acid, salicyluric acid, salicylic acid, 2,3- 
dihydroxybenzoic acid, 2,5-dihydroxybenzoic acid, (Aldrich Chem.Co.); HPLC giade sodium 
acetate trihydrate, (Fisons); HPLC grade water and methanol (Rathburn Chem.Ltd.); benzoic acid, 
tri-sodium citrate, acetic acid, 35% ammonia solution, hydrochloric acid sp.gr. 1.18 (BDH 
Lab. Supplies).
1.2 Serum specimens for standard cuiwes
Blood samples were taken from volunteers from the Biochemistry Department, Dumfries and 
Galloway Royal Infirmaiy. These volunteers were not consuming aspirin. The samples were left to 
coagulate for 30 minutes before being spun in a centrifuge at 3000g for 10 minutes. The serum 
was then removed and stored at -30°C.
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2. APPARATUS
2.1 HPLC apparatus
The HPLC system consisted of a Jasco 851-AS Intelligent Sampler, a Jasco PU-980 Intelligent 
HPLC Pump, a Jasco LG-980-02 Ternaiy Gradient Unit, a Jour Research X-Act 4 Channel 
Degasser and an Antec Decade Electrochemical Detector (Presearch). Data was acquired using 
Minichrom, a chromatography data capture system which processes raw data, via an ETHERNET 
network using a VG Chromatography Server (Fisons). The analytical column was a 25cm x 
4.6mm Apex Octadecyl 5q Column (Jones Chromatography) and the column was held within the 
main cavity of the electrochemical detector at a constant temperature of 30°C. A combination pH 
electrode (Russell Electrodes) was used to measure pH. All solutions were filtered through 0.22 
micron filters (MSI), an injection loop of lOOjal was used and the flow rate was 1 .Oml/min. 
Identification of peaks was by comparison of retention times (t,) with standard material. Straight 
line calibration curves were calculated by peak height ratios of extracted material with IS.
2.2 SPE apparatus
The SPE system consisted of a Vac-Elut Extraction System and SPE Columns - HAX 
200mg/10ml XL Column Reservoir (Jones Chromatography) and a Techne Dri-Block DB-3 &
SC3 Sample Concentrator (Techne (Cambridge) Ltd.)
2.2.1 SPE procedure
Solid phase columns were placed on the Vac-Elut system and to each individual column was 
added 2mls of methanol (column solvation) followed by 2mls of acetate buffer (9.6mM) adjusted 
to pH 2.5 using glacial acetic acid (column pre-equilibration). The specimen was added to the 
column reservoir and allowed to flow through the column (no vacuum necessary at this stage). 1ml 
of pH 2.5 acetate buffer was used to "wash" the column and then allowed to diy under
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vacuum for 5 minutes. A rack of screw-capped glass tubes were placed on the Vac-Elut system 
and the tip of the deliveiy needle wiped diy. 5mls of a 3%(v/v) ammonia in methanol was added to 
the column and the eluent collected. The eluent was evaporated at 55°C under a stream of 
nitrogen, reconstituted in O.Smls of 0.05M HCl and 50p,l was injected onto the analytical column.
2.3 Calculating extraction efficiencies
Detection of a substance by the ECD was represented on the chromatogram by a peak. In order to 
determine the efficiency of extraction for SA (or 2,3-DHBA and 2,5-DHBA) using peak heights, a 
known amount of SA is added to serum, extracted and injected and peak heights compared against 
a known amount of standard SA injected. The following relationship is then applied:
Extraction efficiency = Peak height of SA from extracted sample x 100 
of SA Peak height of SA from standard solution
34
3 METHOD DEVELOPMENT AND VALIDATION OF SA ASSAY
3.1 Mobile phase
When the method was set up at first there was no methanol present in the mobile phase (tri-sodium 
citrate (30mM) with the pH adjusted to 4.75 using glacial acetic acid). When a standard SA 
solution was injected the f  of the corresponding peak was 28 minutes, hi order to tiy and elute the 
SA peak more quickly, 4 mobile phases were prepared, each consisting of a different methanolic 
concentration. 50pM standards of SA were prepared and analysed to see where the analyte peak 
eluted.
3.2 Blank sera specimen analysis
Serum that had been stored at -30°C was thawed and l.OM hydrochloric acid (HCl) added to 
0.5ml aliquots to bring them to a pH of about 2.5. Serum was extracted and analysed in order to 
look at the quality of the chromatography produced.
3.3 Voltammetric behaviour of SA
3.3.1 Voltammetric behaviour of SA at a glassy carbon electrode
A ImM stock solution of SA in water was prepared and made up to a final concentration of lOpM. 
50jal of this stock solution was then injected onto the column (69ng of SA) and the Box of the ECD 
was varied between 0.90 and 1.30V. It was believed that the Eqx for SA would be higher than that 
for 2,3-DHBA since there is one less hydroxyl group.
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3.3.2 Voltammetric comparison of standard SA and blank sera peaks having the same 
retention time (t,..) using SPE.
0.5mls of human serum from subjects known not to have taken aspirin was adjusted to pH 2.5 
using 1 .OM HCl and extracted using SPE. A IniM stock solution of SA in water was prepared and 
diluted to produce a solution containing 500nM of SA. The Eqx of the ECD was varied between 
1.10-1.25V and the blank extract and the standard SA were injected onto the analytical column to 
provide peak height response at the different Eox voltages. Peak height ratios for both the serum 
and standard injections were calculated using the acquired data.
3.4 Extraction efficiency of SA
3.4.1 Extraction efficiency of SA from human serum
7mls of serum was thawed, adjusted to pH 2.5 using l.OM HCl and divided into 7 equal aliquots. 
One of these aliquots was kept as a blank and the remaining 6 were spiked with different amounts 
of SA (0.625, 1.25, 2.5, 5.0, 10 and 20nmol/nil). Extraction efficiencies for SA were calculated as 
described in section 2.3, p.34.
3.4.2 Effect on extraction efficiencies of SA by vaiwing the serum pH before extraction
An experiment was carried out to determine the effect of vaiying the serum pH from the proposed 
pH of 2.5 during sample preparation, prior to SPE. As part of method robustness it was essential to 
ensure that the extraction efficiencies would not vary significantly with small changes in pH of the 
serum. Five separate 1.0ml aliquots of serum were spiked with 50pM SA and prepared by adding 
different amounts of 1 .OM HCl. This provided a range of serum pH values around pH 2.5, the pH 
at which it was thought maximum extraction efficiencies would be attained. The pH of the five 
serum samples were 2.07, 2.33, 2.42, 2.53, and 2.71. These samples were extracted as described in 
section 2.2.1, p.33 and extraction efficiencies calculated.
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3.5 Internai standard (IS) for SA assay
Various compounds with structural similarities to SA were investigated as possible IS. Four 
important factors had to be taken into consideration in the search for a suitable IS and these were: 
the voltammetric behaviour of the compound; the SPE behaviour; the t^  and resolution of peaks in 
the chromatogram; and the compound chosen should not be produced by metabolic pathways.
3.5.1 Compounds examined for suitability as an IS
Table 4, p.56 shows the compounds that were tested to discover whether or not they would be 
suitable to be used as an IS. The mobile phase used on days 1, 2 and 3 contained 20%(v/v) 
methanol in tri-sodium citrate (30mM) with the pH adjusted to 4.75 using glacial acetic acid. On 
day 4 the mobile phase consisted of a methanolic concentration of 16.7%(v/v). A lOpM standard 
solution of SA and 50pM of each potential IS were prepared and injected onto the analytical 
column to determine the f  of each with respect to each other. In each experiment, extraction of 
human blank serum was carried out to indicate what regions of a blank chromatogram were 
available for “insertion” of trial ISs.
3.5.2 Voltammetric behaviour of 2,5-dihydroxyphenylacetic acid y lactone (2,5-DHPAAGL) 
at a glassy carbon electrode
A ImM stock solution of 2,5-DHPAAGL was prepared and diluted to a final concentration of 
lOpM. 50pl of the lOpM 2,5-DHPAAGL solution was injected onto the column with the Eox of 
the ECD varied between 0.70 and 1.15V. A mobile phase consisting of 20%(v/v) methanol in tri­
sodium citrate (30mM) was adjusted to pFI 4.75 using glacial acetic acid.
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3 .5.3 SPE of 2,5-DHPAAGL
Baseline resolution of the 2,5-DHPAAGL and SA was achieved and both peaks were free from 
interference from blank serum, therefore SPE was carried out to ensure that the 2,5-DHPAAGL 
was extracting efficiently.
ImM stock solutions of 2,5-DHPAAGL and SA were prepared, diluted and 50pl of lOpM 2,5- 
DHPAAGL and SA standards were injected onto the analytical column. Blank serum was thawed 
and the pH adjusted to 2.5 using 1 .OM HCl. The serum was spiked with 50pl of lOOpM 2,5- 
DHPAAGL and 50pl of lOOpM SA. Spiked and unspiked sera were extracted in duplicate and 
prepared for analysis. The extracts were injected onto the analytical column. The fr of the extracted 
peaks were compared with the fr of standard 2,5-DHPAAGL and SA peaks. The mobile phase 
consisted of 20%(v/v) methanol in tri-sodium citrate (30mM) with the pH adjusted to 4.75 using 
glacial acetic acid.
3.5.4 SPE of 4-methvlsalicyIic acid (4-MeSA)
4-MeSA and 3-methylsalicylic acid (3-MeSA) were both well resolved from SA and were free 
from interference from blank serum. 4-MeSA was considered first since the f  was shorter than that 
of 3-MeSA and a standard solution of 3-MeSA was found to have an impurity present which 
produced another peak in the chromatography. ImM stock solutions of both SA and 4-MeSA were 
prepared, diluted and 50pl of each lOpM standard solution injected onto the column. 3mis of sera 
was thawed and adjusted to pH 2.5 using l.OM HCl and divided into 3 equal aliquots of 1ml. One 
aliquot of serum was spiked with 50pl of lOOpM 4MeSA and 50p,l of lOOpM SA, another with 
50pl of lOOpM SA and the final aliquot was used as a blank. The aliquots were extracted in 
duplicate (2 x 0.5ml) and the tr of standard solutions and extracted samples for 4-MeSA and SA 
were compared after injection onto the column. The mobile phase consisted of 28.6%(v/v) 
methanol in tri-sodium citrate (30mM) with the pH adjusted to 4.75 using glacial acetic acid. It
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was hoped that the increased methanol content in the mobile phase would allow faster elution of 
the 4-MeSA peak.
3.5.5 Voltammetric behaviour of 4-MeSA at a glassy carbon electrode
In order to optimise the chromatographic conditions a voltammogram was carried out, A ImM 
stock solution of 4-MeSA was prepared and diluted. 50pl of a lOpM 4-MeSA standard was 
injected onto the column with the Eox on the ECD varied between 0.90 and 1.25V.
3.5.6 Extraction efficiency of 4-MeSA
6mls of serum was thawed, adjusted to pH 2.5 using l.OM HCl and divided into 6 equal aliquots 
of 1ml. One aliquot was used as a blank and the remaining 5 were spiked with different 
concentrations of 4-MeSA. The extraction efficiency of 4-MeSA was determined. The mobile 
phase consisted of 28.6%(v/v) methanol in citrate/acetate with the pH adjusted to 4.75 using 
glacial acetic acid.
3.5.7 Linearity of 4-MeSA
A ImM stock solution of 4-MeSA was prepared and diluted. 16 different concentrations of 4- 
MeSA were injected onto the column and the peak height plotted against the concentration of 4- 
MeSA injected.
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3.6 Range and linearity
3.6.1 Range and linearity of SA
The linearity of SA after extraction was determined over the concentration range 0.1-50)liM. This 
was the range anticipated in the serum of patients receiving low dose aspirin. 50|ll1 volumes of 
different concentrations of standard SA solutions were added to 0.5ml aliquots of pooled human 
control serum and acidified to pH 2.5 using l.OM HCl.
3.6.2 Level of IS required for calibration curves
The median serum level of SA expected during low dose aspirin therapy was lOpmol/l. In order to 
arrive at an appropriate concentration of IS (4-MeSA) to spike the serum with, it was estimated 
that a 25jLimol/l solution of 4-MeSA would give a peak height ratio of SA/IS of 1 at the lOjmnol/ml 
SA concentration. 50pi injections of aqueous SA (1.5, 15 & 45pmol/l) and 4-MeSA (25pmol/l) 
were made onto the HPLC system at an Eox of 1.1 OV.
The detector response of both compounds were compared after extraction, and a 4-MeSA 
concentration selected based on the extraction recovery of 4-MeSA relative to that of SA.
3.6.3 Pooled serum from patients
Serum from patients was collected and then assayed to ensure that no subjects had taken any 
aspirin. Serum samples were pooled from patients and aliquotted into 6 equal groups. The pooled 
sera in each group was thoroughly mixed and the pH of each pool was adjusted to pH 2.5 using 
l.OM HCl and extracted in duplicate. This serum was to be used for preparation of standards for 
calibration curves.
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3.6.4 Extracted SA calibration cuiwe from human serum
A range of SA concentrations in pooled human serum were prepared between 0.1-50pM. 4-MeSA 
was added to give a final concentration in extracted serum of 25pM at each level. These samples 
were extracted and analysed by HPLC with ECD at an Eqx of 1. lOV.
3.7 Inter and intra-assay precision and accuracy of SA analysis
Concentrations of SA in pooled human serum were prepared within the concentration range of the 
calibration curve at concentrations of 1.5, 15 and 35pM. Aliquots of these solutions were stored at 
-30°C during the timescale of the precision analysis. Sufficient serum standards were prepared to 
allow 10 determinations at each concentration on a single day and for duplicate measurement to be 
made at each concentration on 10 separate days to provide data for both intra and inter-assay 
precision respectively. Aliquots were thawed and analysed by reference to calibration standards 
(1, 5, 10, 20 & 50pM) prepared using pooled human serum on the day of measurement of the 
stored specimens. The data generated was compared with expected concentrations of freshly 
prepared standards as an estimate of accuracy for the SA analysis.
3.8 Stability of SA
3.8.1 Stability of aqueous SA stored at 3 different temperatures
ImM stock solutions of standard SA and IS were prepared and diluted to give aliquots consisting 
of concentrations of 1.5, 15 & 35|xM. These were stored in glass tubes with teflon lined screw 
caps at room temperature, 4“C and -30°C over a period of 20 days. Aliquots were removed and 
analysed by direct injection onto the column with the Eqx of the ECD set at 1.1 OV.
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3.8.2 Stability of SA made up in 0.05M HCl and water
ImM stock solutions of SA made up in both 0.05M HCl and water were prepared to investigate 
the effect of pH on the stability of SA. Aliquots were stored at -30°C and investigated as described 
above covering a period of 11 days.
3.8.3 Stability of SA in serum stored at serum pH and pH 2.5
1.5, 15 and 35|liM concentrations of SA were prepared in serum with the pH adjusted to 2.5 with 
IM HCl or in serum where no HCl was added (pH 7.5-7.8). Aliquots of serum were stored in glass 
tubes at -30“C. These were removed at intervals covering a period of 13 days, extracted and 
analysed.
3.9 Clinical application
3.9.1 Measurement of SA levels in 8 diabetic patients taking low dose aspirin
Blood samples collected from diabetic outpatients at Dumfries and Galloway Acute & Maternity 
National Health Service Trust, who were known to be taking aspirin at low dose levels (75- 
300mg/day), were allowed to clot and the serum was separated after centrifugation and stored at 
-30°C until analysis. The 8 samples were thawed, mixed and O.Smls extracted and analysed in 
duplicate. The aspirin dose was recorded for each subject but not the time after dosing that the 
blood sample was taken.
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4. METHOD DEVELOPMENT OF 2,3-DHBA AND 2,5-DHBA ASSAY
4.1 SPE procedure
The SPE procedure was the same as used for the SA assay described previously in section 2.2.1, 
p.33.
4.2 Voltammetric behaviour of 2,3-DHBA and 2,5-DHBA at a glassy carbon electrode
ImM stock solutions of 2,3-DHBA and 2,5-DHBA were prepared and diluted to give a 
concentration of lOnM. 50p,l of each standard solution was injected onto the analytical column 
and the Eov of the ECD varied between 0.35 and 0.80V.
4.3 Confirmation of the presence of 2,3-DHBA and 2,5-DHBA in human blank serum
4.3.1 Patient samples (n = ll) analysed for the presence of 2,3-DHBA and 2,5-DHBA.
Blood samples were taken from 11 subjects known not to be taking aspirin. Serum was removed 
and the pH adjusted to 2.5 using l.OM HCl. Following extraction, chromatograms of extracted 
serum and standard 2,3-DHBA and 2,5-DHBA were compared. The Eqx was 0.75V.
4.3.2 Comparison of peak height ratios for blank serum unknown peaks, 2,3-DHBA and 
2,5-DHBA by vaiwing the Env.
Blank serum was adjusted to pFI 2.5 using 1 .OM HCl and extracted. ImM stock solutions of 2,3- 
DFIBA and 2,5-DHBA were prepared and diluted to a concentration of lOnM. Three different E^ 
values were applied (0.45, 0.55 and 0.65V) to compare peak height ratios of 2,3-DHBA and 2,5- 
DFFBA at the different Eqx values against those of the unknown peaks with identical f  to 2,3- 
DHBA and 2,5-DFEBA in extracted blank serum.
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4.4 Extraction efficiencies of 2,3-DHBA and 2,5-DHBA
6mls of human blank serum were thawed, the pH adjusted to 2.5 using l.OM HCl and divided into 
6 equal aliquots of 1ml. Two of these were used as blanks, 2 were spiked with lOOnM of 2,3- 
DHBA and the final 2 spiked with lOOiiM of 2,5-DHBA.
4.5 Stability of 2,3-DHBA and 2,5-DHBA while using the HPLC autosamiiler
ImM stock solutions of 2,3-DHBA and 2,5-DHBA were prepared in water, diluted to a 
concentration of lOOnM and 50pl injected onto the column using the autosampler. Nine injections 
of a mixture of 2,3-DHBA and 2,5-DHBA were run over a period of 4 hours. The Eox was 0.75V.
4.6 IS for 2,3-DHBA and 2,5-DHBA assay
4.6.1 3,4-diliY(lroxyphenylacetic acid (3,4-DHPAA)
3,4-DHPAA had been used in previous work carried out by a group at the Royal Infirmary in 
Glasgow. This compound was known to be well resolved from 2,3-DHBA and 2,5-DHBA and it 
was thought it could be used as the IS. No other method development work had been carried out 
using 3,4-DHPAA.
4.6.2 Voltammetric behaviour of 3,4-DHPAA at a glassy carbon electrode
A ImM stock solution of 3,4-DHPAA was prepared and diluted to a concentration of lOnM. 50pl 
of the lOnM solution was injected onto the column and the Eox of the ECD was varied between 
0.35 and 0.80V.
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4.6.3 Stability of 3,4-DHPAA while using the HPLC autosamnler
ImM stock solutions of 2,3-DHBA, 2,5-DHBA and 3,4-DHPAA were prepared in water and 
diluted to give a lOOnM mixture of 2,3-DHBA, 2,5-DHBA and 3,4-DHPAA. A series of 50 pi 
injections of the mixture were injected onto the analytical column and data recorded. The Eqx was
0.75V.
4.6.4 Continued search for a suitable IS for 2,3-DHBA and 2,5-DHBA assay 
Using the basis for choosing an IS described previously in section 3.5, p.37, six potential 
candidates were investigated further:
1/ 3,4-dihydroxybenzoic acid 3/ 3,5-dihydroxybenzoic acid 5/ 4-hydroxybenzoic acid 
2/ 2,4-dihydroxybenzoic acid 4/ 3-hydroxybenzoic acid 6/ 3,4,5-trihydroxybenzoic acid
A ImM stock solution of each of the above compounds was prepared in 0.05M HCl and diluted to 
a concentration of lOOnM. 50pl of each compound was manually injected onto the column. The 
Eox was 0.75V.
4.6.5 Stability of 3,4-dihydroxybenzoic acid (3,4-DHBAI
A ImM stock solution of 3,4-DHBA was prepared, diluted and assayed to ensure stability in 3 
different aqueous environments including water, 0.05M HCl and mobile phase. The stability was 
tested over a period of 10 hours at room temperature. The Eox was 0.75V.
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4.7 Optimisation of chromatographic and extraction conditions.
Mobile phase consisting of tri-sodium citrate (30mM) with the pH adjusted to 4.75 using glacial 
acetic acid, resulted in slight overlap of the 2,3-DHBA and 2,5-DHBA peaks. In order to produce 
better resolution of these two analytes, the chromatographic conditions were altered.
4.7.1 Tri-sodium citrate (SOmMl mobile phase at pH 4.75 examining the effect of overlap of 
2,3-DHBA, 2,5-DHBA and 3,4-DHBA peaks with increasing analyte concentration
A mobile phase was prepared consisting of tri-sodium citrate (30mM) with the pH adjusted to 4.75 
using glacial acetic acid. 3 mixtures containing different concentrations of each were prepared in 
water (30, 100, 170nM each of 2,3-DHBA, 2,5-DHBA and 3,4-DHBA) and 50pi injected onto the 
column to see what effect increased concentration would have on the resolution of the peaks. 
These concentrations were chosen because they were thought to be in the approximate range of 
levels ill subjects taking low-dose aspirin.
4.8 Search for a more suitable mobile phase
4.8.1 Addition of 4.75% acetonitrile to the mobile phase
A mobile phase was prepared containing 4.75% acetonitrile(v/v) in tri-sodium citrate (30mM) 
with the pH adjusted to 4.75 using glacial acetic acid. lOOnM solutions of 2,3-DHBA and 2,5- 
DHBA were prepared from ImM stock solutions and 50pl of each was manually injected to 
ascertain whether better resolution had been achieved.
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4.8.2 Addition of 1.5% methanol to the mobile phase
A mobile phase was prepared containing 1.5% methanol in tri-sodium citrate (30mM) with the pH 
adjusted to 4.75 using glacial acetic acid. The same solutions as in Exp 4.8.1 were used and the 
same amount manually injected.
4.8.3 Variation in pH of the mobile phase
The pH of the tri-sodium citrate (30mM) mobile phase was varied with pH values of 4.75, 5.0, 5.2,
5.3 and 5.4 being investigated. A lOOnM aqueous mixture of 2,3-DHBA, 2,5-DHBA and 3,4- 
DHBA was prepared and 50pl injected onto the column. Chromatographic data, including the tr of 
the analytes, using the different mobile phases were collected. The effect of the mobile phase pH 
on detector response of the compounds of interest was investigated also.
4.9 Optimisation of SPE for 2,3-DHBA and 2,5-DHBA assay.
4.9.1 Analysis of SPE eluent fractions for 2,3-DHBA and 2,5-DHBA
During SPE, 5mls of eluent (3%(v/v) ammonia in methanol) were added to the solid phase column 
to elute the 2,3-DHBA and 2,5-DHBA. In order to examine this elution process, 0.5ml fractions 
were collected, dried under nitrogen at 55°C, reconstituted in 0.5mis of 0.05M HCl and 50pi of 
each extract injected onto the analytical column. From each 0.5ml increment collected, recoveries 
were calculated to see how much of each analyte was present in each 0.5ml fraction.
4.9.2 SPE using new mobile phase
A mobile phase of tri-sodium citrate (30mM) with the pH adjusted to 5.3 using glacial acetic acid 
was prepared. A serum sample from a subject not consuming aspirin was extracted. 50pi of the 
extract was injected onto the column to determine changes in f  of unknown peaks from blank
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serum using the new mobile phase. These were compared to standard mixtures of the 3 analytes of 
interest.
4.9.3 Setting up a gradient to elute unwanted peaks
The use of gradient elution was investigated in order to reduce the amount of time between 
injections, since it had been observed that some peaks in the serum extracts had a f  of 120 
minutes. Two mobile phases were used in order to set up the gradient: A - tri-sodium citrate 
(30mM) with a pH of 5.3; B -28.6%(v/v) methanol in tri-sodium citrate (30niM) with a pH of 5.3. 
Four different gradient programmes were set up on the gradient unit and are shown below.
Program 1
Time (mins) Step time (mins) %A %B
0.0 0.0 100 0
9.5 9.5 100 0
14.5 5.0 0 100
20.0 5.5 0 100
22.0 2.0 100 0
Program 2
Time (mins) Step time (mins) %A %B
0.0 0.0 100 0
7.0 7,0 100 0
8.0 1.0 0 100
15.0 7.0 0 100
16.0 1.0 100 0
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Program 3
Time (mins) Step time (mins) %A %B
0.0 0.0 100 0
6.0 6.0 100 0
6.1 0.1 0 100
15.0 8.9 0 100
15.1 0.1 100 0
Program 4
Time (mins) Step time (mins) %A %B
0.0 0.0 100 0
6.0 6.0 100 0
6.1 0.1 0 100
17.5 11.4 0 100
17.6 0.1 100 0
4.10 CariTover o f peaks
4.10.1 Checking for carryover of peaks
Gradient program 3 was found to give the quickest throughput of samples using the mobile phases 
A and B as described in section 4.9.3, p.48. A serum sample was extracted and the gradient 
program used to inject the extracted serum sample followed by mobile phase to check for 
cariyover of the 2,3-DHBA, 2,5-DHBA and 3,4-DHBA from serum.
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4.10.2 The effect of the number of washes of the aiitosampler needle on carryover
Gradient program 3 was used and an aqueous mixture of 2,3-DHBA, 2,5-DHBA and 3,4-DHBA 
was prepared (170nM of each). The washing feature on the autosampler allows a maximum of 5 
washes between injections. Five samples were injected, and the number of washes varied between 
1 and 5, to see what effect the number of washes would have on carryover. The wash solution was 
50% methanol(v/v) in 0.05M HCl.
4.10.3 Investigation of different wash solutions
Four wash fluids were examined, including: 50% methanol(v/v) in 0.05M HCl (5 washes) with the 
outside of the autosampler needle wiped thoroughly; 0.05M HCl on its own (5 washes); O.IM HCl 
to see if a stronger acid could prevent the carryover from occurring (5 washes); 0.2M FICl (5 
washes). Stock solutions of 2,3-DHBA, 2,5-DFIBA and 3,4-DHBA were prepared to a 
concentration of 170nM each and the post wash solution was 0.05M HCl.
50
RESULTS
1. METHOD DEVELOPMENT AND VALIDATION OF SA ASSAY
1.1 Mobile Phase
The tr of the SA with different methanolic concentrations in the mobile phase are shown in Table 
1, p.52. From this it was shown that for a mobile phase consisting of 28.6%(v/v) methanol, the SA 
peak eluted with a of about 6 minutes. A peak in the chromatogram of the serum blank shown in 
Fig. 5a, p.54 at a tr of approximately 5 minutes did not allow further optimisation of the mobile 
phase conditions. It was believed that a further increase in the organic content of the mobile phase 
would reduce the resolution between the peak in the blank sera and the SA peak.
1.2 Blank sera specimen analysis
A typical chromatogram showing an extracted blank serum sample from a subject not consuming 
aspirin is shown in Fig. 5a, p.54. The mobile phase used consisted of 28.6%(v/v) methanol.
1.3 Voltammetric beliayiour of SA
1.3.1 Voltammetric behayiour of SA at a glassy carbon electrode
A voltammogram was drawn for SA (Fig.6a, p.58). The optimum potential for the determination 
of SA was found from the position of the plateau on the hydrodynamic wave, in this case around 
I.IOV.
1.3.2 Voltammetric comparison of standard SA and blank sera peaks having the same t, 
using SPE
At maximum sensitivity, a peak occurred at the same f  as SA in the "blank" sera. Voltammograms 
were drawn indicating that the blank peak was probably due to SA. Cariyover from previous
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injections was carefully excluded (Table 2, p.52). All blank sera were found to contain SA at 
concentrations less than 75pmol/ml.
Table 1 The retention times (tr ) of SA using different concentrations of methanol in the mobile 
phase (30mM sodium citrate/acetate with the pH adjusted to pH 4.75 using glacial 
acetic acid).
Methanol concentration
% (v/v)
tr of SA 
(mins)
9.0 11.94
16.7 8.01
20.0 6.83
28.6 5.82
Table 2 A voltammetric comparison of SA and a compound present in all blank sera having the 
same t .
Eox(V) Standard peak height in mm 
(% change from I.IOV)
Blank sera peak height 
(%change froml.lOV)
1.10 18.3 1.5
1.15 46.1 (252) 3.3 (220)
1.20 127.5 (697) 9.6 (640)
1.25 55.1 (301) 3.6(240)
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1.4 Extraction efficiency of SA
1.4.1 Extraction efficiency of SA from human serum
The mean extraction efficiency of SA was found to be 85% (CV = 12.6%, n=6).
1.4.2 Effect on extraction efficiencies of SA by vaiwing the serum pH before extraction
The effect of vaiying the pH of serum samples before application to the solid phase columns is 
shown in Table 3, p.55. From the table we can see that the extraction efficiencies were >96% 
across the pH range 2.07-2.71.
1.5 IS for SA assay
1.5.1 Compounds examined for suitability as an IS
The tr of various compounds which were investigated to see whether they could be used as IS are 
shown in Table 4, p.56. Of the compounds analysed, very few were considered as potential IS. A 
number of the compounds did not oxidise at the Eox of SA (1.1 OV), therefore no peak on the 
chromatogram was detected, some interfered with endogenous peaks present in blank serum and 
others co-eluted with the SA peak. 2,5 DHPAAGL had a f  of 10.42 minutes, compared to 6.90 
minutes for SA and was the first compound to be investigated as a potential IS. It did not interfere 
with any of the peaks extracted from blank serum. 4-MeSA and 3-MeSA oxidised at the same Eox 
as SA and were well resolved from interfering peaks, but had longer elution times.
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Fig. 5 Chromatograms of (a) extracted blank serum from a healthy volunteer not consuming 
aspirin, (b) blank serum spiked with SA and 4-MeSA and extracted and (c) human 
serum from a volunteer taking low dose aspirin spiked with IS and extracted.
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Table 3 The effect of pH on extraction efficiencies of SA in human serum.
Volume of l.OM HCi added 
(ftl)
Serum pH Extraction efficiency of SA 
(%)
130 2.07 96
128 2.33 98
126 2.42 98
125 2.53 101
120 2.71 102
1-5.2 Voltammetric behaviour of 2,5-DHPAAGL at a glassy carbon electrode
A voltammogram was drawn for 2,5-DHPAAGL by plotting the recorded peak height, which 
corresponds to peak current, versus the applied Box between the range 0.70-1.15V. The optimum 
potential for the determination of 2,5-DHPAAGL was found from the position of the plateau on 
the hydrodynamic wave, in this case around 1.1 OV, veiy similar to that of SA.
1.5 .3 SPE of 2,5-DHPAAGL
The tr of standard solutions of SA and 2,5-DHPAAGL were found to be 6.72 and 10.57 minutes 
respectively. After SPE, an unspiked extract of serum was injected onto the analytical column and 
there was found to be no interfering peak present at the tr of the standard 2,5-DHPAAGL. 
Thereafter, the spiked extract was injected and no peak was observed at the f  of 2,5-DHPAAGL. 
This extraction process was repeated with the same result indicating that 2,5-DHPAAGL was 
either not extracted or that it was unstable.
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Table 4 List of compounds investigated for possible use as the IS for SA
NAM E OF COMPOUND RT (mins) RT o f SA (mins)
3-methoxysalicylic acid (1) 6,58 6.87
benzoic acid (1) ND 6.87
3,4,5-trihydroxybenzoic acid (1) 2.96 6.87
4-liydroxybenzoic acid (1) 5.88 6.87
3-hydroxybenzoic acid (1) 5.52 6.87
2,4-dihydroxybenzoic acid (1) 3.44 6.87
3,4-dihydroxybenzoic acid (1) 3.96 6.87
3,5-dihydroxybenzoic acid (1) 3.15 6.87
2,3-dimetlioxybenzoic acid (2) ND 6.90
3-methoxybenzoic acid (2) ND 6.90
3-hydroxy-4-methoxybenzoic acid (2) 7.48 6.90
3-hydroxy-4-methylbenzoic acid (2) 18.15 6.90
2-iiydroxy-3-isopropylbenzoic acid (2) ND 6.90
2,5-diiiydroxyphenytacetic acid (2) 3.43 6.90
2,5-dihdroxypheiiylacetic acid gamma-lactone (2) 10.42 6.90
2-bromobenzoic acid (3) ND 6.79
2-chlorobenzoic acid (3) ND 6.79
2-iodobenzoic acid (3) 6.78 6.79
3-fluorobenzoic acid (3) ND 6.79
3-methylsalicylic acid (4) 24.13 8.15
4-methylsalicyiic acid (4) 19.72 8.15
ND - no peak detected.
(1), (2), (3) & (4) - corresponds to the 4 days on which analysis took place.
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1.5.4 SPE of 4-MeSA
The tr of SA and 4-MeSA were found to be 5.82 and 11.78 minutes respectively. After SPE, the 
blank serum sample was injected and there was found to be no interfering peak present at the tr of 
4-MeSA (11.78 minutes). Following injections of the extract spiked with 4-MeSA and SA, two 
peaks were observed which eluted at the same f  as standard 4-MeSA and SA (Fig.5b, p.54).
1.5.5 Voltammetric behaviour of 4-MeSA at a glassy carbon electrode
A voltammogram was drawn for 4-MeSA (Fig.6b, p.58), with the optimum applied Eox for the 
determination of 4-MeSA found from the position of the plateau on the hydrodynamic wave, in 
this case sufficiently close to that of SA (1,10V) to allow the latter to be used for the detection of 
both compounds with acceptable sensitivity.
1.5.6 Extraction efficiency of 4-MeSA assay
The mean extraetion efficiency of 4-MeSA from serum was found to be 91% (CV = 4.1%, n=5). 
Results were calculated by comparing peak areas of standard solutions of 4-MeSA with equivalent 
concentrations to those of the extracts.
1.5.7 Linearity of 4-MeSA assay
The 4-MeSA peak response was found to be linear over a concentration range of 0.1-50pM.
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Fig. 6 Voltammogram of (a) SA and (b) 4-MeSA
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1.6 Range and linearity
1.6.1 Range and linearity of SA analysis
The SA peak response was linear over a concentration range of 0. l-50pM with a linear regression 
equation y = 0.244286x(+/-0.003007) -2.429(+/-l .518) where n=8 and the standard error s =
1.949. The limit of detection defined as that amount of solute producing a signal three times the 
standard deviation of the noise was 15pmol/ml (lOSpg) of SA.
1.6.2 Level of IS required for calibration cui-yes
The level of IS required for calibration curves to allow accurate peak quantitation across the 0.1- 
50jliM SA standards range was found to be 25 pM. This gave a peak/height ratio of around 1 at the 
median serum level of SA expected during low dose aspirin therapy.
1.6.3 Pooled serum from patients
6 pools of serum from 5 patients were analysed and it was found that 2 out of 6 of the gi'oups had 
interfering peaks from patients who had taken aspirin. The resulting 4 group’s sera were pooled 
together, and aliquots of 3mis stored in the freezer at -30”C for use as blank sera in the preparation 
of standard curves.
1.6.4 Extracted SA calibration cui-ve from human serum
A typical standard cuive covering the concentration range expected from subjects consuming low 
dose aspirin is shown in Fig.7, p.60 with correlation coefficients greater than 0.997 in all cases. 
Correlation coefficients were calculated by the Minicluom data handling system.
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Fig.7 A typical standard curve of peak height ratio versus SA concentration (pM).
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1.7 Inter and intra-assav precision of SA analysis
The results of the inter and intra assay precision of 3 levels prepared and stored at -30°C are shown 
below in Tables 5-8, p.62 & 63. Intra-assay precision was better than that of inter-assay, as 
expected, and in both cases improved with increasing concentration.
1.8 In ter and intra-assav accuracy of SA analysis
Inter-assay accuracy of SA at 1.5pM, ISpM and 35pM was found to be 87.1%, 87.0% and 94.0% 
respectively, where n = 9 at each concentration. Intra-assay accuracy of SA at 1.5pM, 15pM and 
35pM was found to be 84.1%, 94.7% and 93.4% respectively, where n = 10 at l.SpM and 35pM 
and n = 9 at 15pM.
1.9 Stability of SA
After 13 days of storage there were no significant changes (outwith the inter assay precision) in 
the 1.5, 15 and 35pM solutions of SA in water and HCI kept at room temperature, or in serum at 
pH 7.3-7.5 and pH 2.5 kept at -30°C. However, when aqueous solutions of SA were examined 
after 20 days at room temperature, 4°C and -30°C the 1.5pM solution alone showed a significant 
decline of 18.2%.
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Table 5 Inter-assay results at 3 concentrations of SA after extraction from human serum.
DAY NO SA CONCENTRATION 
(pM)
1 1.32 11.35 33.05
2 1.79 14.15 38.88
3 1.31 11.98 35.66
4 1.69 13.56 39.90
5 1.37 11.73 34.50
6 1.47 12,85 35.05
7 1.54 12.96 35.99
8 1.63 14.10 39.61
9 2.14 14.27 36.36
Table 6 Inter-assay variation at 3 concentrations of SA after extraction from human serum.
MEAN (pM) CV (No.of samples)
LOW(1.5pM) 1.58 16.9% (11=9)
MED (15pM) 12.99 8.5% (ii=9)
HIGH (35pM) 36.56 6.6% (n=9)
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Table 7 Intra-assay results at 3 concentrations of SA after extraction from human serum.
SAMPLE NO. SA CONCENTRATION 
(pM)
1 1.55 15.33 38.05
2 1.80 14.55 34.09
3 1.62 13.42 38.53
4 1.82 14.71 37.89
5 1.89 13.88 35.91
6 1.78 15.80 38.62
7 1.85 15.77 35.07
8 1.55 13.43 36.61
9 1.73 14.76 35.59
10 1.80 38.90
Table 8 Intra-assay variation at 3 concentrations of SA after extraction from human serum.
MEAN(pM) CV (No. of samples)
L0W (1.5pM ) 1.74 7.1% (n=10)
M ED(15pM ) 14.63 6.2% (n=9)
HIGH (35|iM) 36.93 4.6% (n=10)
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Table 9 Levels of SA in diabetic patients taking low dose aspirin with corresponding doses.
PATIENT NO. DOSE (mg/day) SA (pM)
1 75 0.62
2 75 3.44
3 75 5.26
4 75 10.51
5 150 0.82
6 150 1.51
7 150 8.93
8 300 0.23
1.10 Clinical application
1.10.1 Measurement of SA levels in 8 diabetic patients taking low close aspirin
The levels of SA in patients taking low dose aspirin are shown in Table 9, p.64 along with 
respective doses. The range of levels to be expected from patients taking low dose aspirin is from 
0.23-10.5 IpM, albeit from a limited number of analyses. The time of the last dose relative to the 
blood sampling time was not recorded, and variations in this interval may add to the variability in 
levels from different administered doses.
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2. METHOD DEVELOPMENT OF 23-DHBA & 2,5-DHBA ASSAY
2.1 Voltammetric behaviour of 2,3-DHBA and 2,5-DHBA at a glassy carbon electrode.
Voltaminograms were drawn for 2,3-DHBA and 2,5-DHBA (Fig.9a & b, p.67). The optimum 
potentials for the determination of 2,3-DHBA and 2,5-DHBA were found from the position of the 
plateaus on the hydrodynamic waves, in this case between 0.70-0.75V for both analytes.
2.2 Confirmation of the presence of 2,3-DHBA and 2,5-DHBA in human blank serum in 
subjects not taking aspirin.
2.2.1 Patient samples (n= ll) analysed for the presence of 2,3-DHBA and 2,5-DEDBA
Chromatograms of all of the patient samples assayed showed the presence of unknown peaks with 
tr identical to 2,3-DHBA and 2,5-DHBA (Fig. 8b, p.66).
2.2.2 Comparison of peak height ratios for blank serum unknown peaks, 2,3-DHBA and
2,5-DHBA by vaiwing the E»v
hi order to obtain evidence of identity beyond similarity of retention time, blank serum extracts 
and standard solutions of 2,3-DFIBA and 2,5-DHBA were subjected to HPLC at Box 0.45V, 0.55V 
and 0.65V. Heights of serum derived peaks with retention times similar to these standards, 
obtained at different Box’s, were expressed as ratios (0.55/0.45 ; 0.65/0.55, 0.65/0.45) and 
compared with those of the standards (Table 10, p.68). Voltammetrically, the bank serum peak of 
tr 6.2 minutes was similar to 2,3-DHBA, while the serum peak of t, 6.6 minute was similar to 2,5- 
DHBA.
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Fig. 8 Chromatograms showing (a) a standard containing 3,4-DHBA, 2,3-DHBA and 
2,5-DHBA (75nM of each) and (b) an extract from a subject known not to have 
consumed aspirin.
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Fig.9 Voltammogram of (a) 2,3-DHBA and (b) 2,5-DHBA.
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Table 10 Verification of peaks from control serum and aspirin takers identified by tr comparison 
of peak height ratios obtained at different Box-
SAMPLES P E A K H E I G H T R A T I O S
DW blank serum 0.55V/0.45V 0.65V/0.45V 0.65V/0.55V
tr of first unknown in blank 
serum: 6.25min 4.00 1.45 5.80
tr of second unknown in 
blank serum: 6.68min 1.50 1.21 1.82
tr of 2,3-DHBA*: 6.21min 4.49 1.28 5.73
tr of 2,5-DHBA*: 6.64min 1.90 1.07 1.97
* - The 2,3-DHBA and 2,5-DHBA standard solutions were both prepared to a concentration of 
lOnM.
Table 11 Stability of 2,3-DHBA and 2,5-DHBA over a period of 4 hours using the autosampler.
Time o f injection 
(Ins)
2,3-DHBA
Pk.ht.(mV)
%Degradation of 
2,3-DHBA
2,5-DHBA
Pk.ht.(inV)
%Degradation. o f 
2,5-DHBA
0 425.7 0.0 479.0 0.0
0.5 420.9 1.2 474.2 2.0
1.0 413.0 3.0 441.3 7.9
1.5 403.9 5.2 438.5 8.5
2.0 416.5 2.2 433.3 9.5
2.5 391.5 8.2 438.7 8,4
3.0 399.4 6.2 367.2 23.7
3.5 348.3 18.3 430.9 10.0
4.0 407.7 4.3 389.0 18.8
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2.3 Extraction efficiencies of 23-DHBA and 2,5-DHBA
The extraction efficiencies of 2,3-DHBA and 2,5-DHBA were calculated in duplicate. Since 2,3- 
DHBA and 2,5-DHBA were thought to be present at low concentrations in the blank sera, the 
extraction efficiencies were calculated by subtracting the peak height of the blank levels from the 
final peak height of the spiked sample. Extraction efficiencies of 79% and 73% for 2,3-DHBA and
2,5-DHBA were calculated respectively.
2.4 Stability of 2,3-DHBA and 2,5-DHBA while using the HPLC autosainnler
Results indicated (Table 11, p.68) that 2,3-DHBA and 2,5-DHBA were only stable in aqueous 
solution for a period of 2.5 hours. This was based on setting an acceptance criteria of less than 
10% degradation of the analyte compared to the peak height of injection at time zero. The results 
show that the two analytes are relatively unstable in aqueous solution.
2.5 IS for 2,3-DBDBA and 2,5-DHBA assay
2.5.1 Voltammetric behayionr of 3,4-DHPAA at a glassy carbon electrode
A voltammogram was drawn for 3,4-DHPAA. The optimum potential for the determination of 3,4- 
DITPAA was found from the position of the plateau on the hydrodynamic wave, in this case 
around 0.70V, similar to the position of the plateau for 2,3-DHBA and 2,5-DHBA.
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2.5.2 Stability of 3,4-DHPAA while using the HPLC autosampler
Repeat injections of 3,4-DHPAA were shown to be stable for only 1.5hrs, but when mixtures of
2,3-DHBA, 2,5-DHBA and 3,4-DHPAA were injected, the 3,4-DHPAA degraded significantly 
faster compared to when 3,4-DHPAA was injected alone (Table 12, p.70). Injections where 
mixtures of 3,4-DHPAA, 2,3-DHBA and 2,5-DHBA were injected are highlighted in the table by 
the use of bold type print.
Table 12 Stability of 3,4-DHPAA over a period of 6 hours using the autosampler.
Injection time 
(hrs)
3,4-DHPAA 
Pk ht(mV)
% Degradation of 
3,4-DHPAA
0.0 253.4 0.0
0.5 238.9 5.7
1.0 158.6 37.4
1.5 230.2 9.2
2.0 198.5 21.7
2.5 111.6 56.0
3.0 195.1 23.0
3.5 222.8 12.1
4.0 62,7 75.3
4.5 202.0 20.3
5.0 168.6 33.5
5.5 52.7 79.2
6.0 192.6 24.0
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2.5.3 Continued search for a suitable IS for 2,3-DHBA and 2,5-DHBA assay
The tr of the 2,3-DHBA and 2,5-DHBA were 8.36 and 8.96 minutes respectively. Of the six 
compounds injected, only two oxidised with the Box at 0.70V. 3,4-DHBA had a tr of 11.35 minutes 
and 3,4,5-trihydroxybenzoic acid a t, of 5.65 minutes.
2.5.4 Stability of 3,4-DHBA
The stability of 3,4-DHBA in different aqueous solutions was carried out over a period of 9 hours.
The results are shown in Tables 13a, b & c, p.80. 1%
2.6 Optimisation of chromatographic and extraction conditions
2.6.1 Tri-sodium citrate (30mM) mobile phase at pH 4.75; examining the effect of overlap of
2,3-DHBA, 2,5-DHBA and 3.4-DHBA peaks with increasing analyte concentration.
As the concentration of the 3 analytes at the 3 different analyte concentrations increased the more 
poorly resolved they became. However at concentrations thought to approximate the levels in 
patients taking low dose aspirin, the resolution of the peaks was satisfactory.
2.7 Search for a more suitable mobile phase
The mobile phase consisting of tri-sodium citrate (30mM) with the pH adjusted to 4.75 using 
glacial acetic acid resulted in the retention times of 2,3-DHBA, 2,5-DHBA and 3,4-DHBA being 
8.34, 8.93 and 11.34 minutes respectively, hi order to baseline resolve the 2,3-DHBA and 2,5- 
DHBA peaks, some alterations to the mobile phase content were made.
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2.7.1 Addition of 4.75% acetonitrile to the mobile phase
Addition of the 4.75% acetonitrile to the mobile phase. In comparison with the original mobile 
phase, the tr of the 2,3-DHBA, 2,5-DHBA and 3,4-DHBA using 4.75% acetonitrile were 5.00,
5.08 and 5.72 minutes respectively. From these results we can see that the acetonitrile causes 
elution of all 3 analytes more quickly but the 2,5-DHBA peak co-elutes with the 2,3-DHBA peak 
giving poorer resolution (Fig. 10a, p.73).
2.7.2 Addition of 1.5% methanol to the mobile phase
The tr for 2,3-DHBA, 2,5-DHBA and 3,4-DHBA when 1.5% methanol was incorporated into the 
mobile phase were 7.18, 7.68 and 8.99 minutes respectively. The addition of methanol made each 
analyte elute more quickly but resolution was not improved over the original mobile phase due to 
“saddling” of the 2,3-DFIBA and 2,5-DHBA peaks (Fig. 10b, p.74).
2.7.3 The effect of vaiwing the pH of the mobile phase on resolution
5 separate mobile phases were prepared with pH values of 4.75, 5.0, 5,2, 5.3 and 5.4 and the tr and 
the detector response of each analyte noted under the different pH conditions (Table 14, p. 81). 
Chromatograms at each pH are shown in Fig.l la-e, p.75-79) which demonstrate the significant 
effect the pH of the mobile phase has on the 3 analytes. As the pH increases from 4.75 - 5.4 the
2,3-DFIBA and 2,5-DHBA peaks move veiy slowly apart i.e. the 2,3-DHBA elutes more quickly 
and the 2,5-DHBA more slowly. As the pH is increased, the 3,4-DHBA peak elutes much more 
rapidly and passes across the 2,3-DITBA and the 2,5-DHBA at pH 5.0 and elutes before them at 
pH 5.2. For eveiy increase in pH of 0.1, the 3,4-DFIBA elutes more quickly by around 0.85 
minutes.
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Fig. 10a Chromatogram showing the effect of adding 4.75% acetonitrile to the mobile phase on
the resolution of 2,3-DHBA, 2,5-DHBA and 3,4-DHBA.
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Fig.lOb Clu’omatogram showing the effect of adding 1.5% methanol to the mobile phase on the
resolution of 2,3-DHBA, 2,5-DHBA and 3,4-DHBA.
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Fig. l i a  Chromatogram showing the effect of pH on the resolution of 2,3-DHBA, 2,5-DHBA
and 3,4-DHBA at pH 4.75.
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Fig. 11b Chromatogram showing the effect of pH on the resolution of 2,3-DHBA, 2,5-DHBA
and 3,4-DHBA at pH 5.0.
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Fig. 11c Chromatogram showing the effect of pH on the resolution of 2,3-DHBA, 2,5-DHBA
and 3,4-DHBA at pH 5.2.
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Fig. l i d  Chromatogram showing the effect of pH on the resolution o f 2,3-DHBA, 2,5-DHBA
and 3,4-DHBA at pH 5.3.
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Fig. I le  Chromatogram showing the effect of pH on the resolution of 2,3-DHBA, 2,5-DHBA
and 3,4~DHBA at pH 5.4.
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Table 13 Stability of 3,4-DHBA over a period of 9 hours in (a) H2O, (b) 0.05M HCl and (c) 
mobile phase (MP)
(b)
3.4 DHBA in HiO 3.4 DHBA inO.OSMHCl
(c)
3.4 DHBA in MP
Time
(Iirs)
PkHt
(mVs)
0 1972.4
4.00 1968.2
4.67 1966.5
5.33 1958.8
6.00 1936.4
6.67 1922.5
7.33 1937.7
8.00 1939.7
8.67 1922.5
Time
(lirs)
PkHt
(mVs)
0 2863.8
4.00 2861.5
4.67 2864.1
5.33 2864.7
6.00 2870.2
6.67 2865.0
7.33 2863.6
8.00 2858.0
8.67 2842.0
Time
(his)
PlcHt
(mVs)
0 2582.7
4.00 2580.2
4.67 2591.5
5.33 2593.8
6.00 2585.2
6.67 2590.4
7.33 2596.7
8.00 2590.7
8.67 2571.9
8 0
Table 14 The tr and detector response of 2,3-DHBA, 2,5-DHBA and 3,4-DHBA under differing 
mobile phase pH conditions.
PkH t
(mVs) t,. (mins)
pH 2,3-DHBA 2,5-DHBA 3,4-DHBA 2,3-DHBA 2,5-DHBA 3,4-DHBA
4.75 2636.3 2493.1 1879.4 8.34 8.93 11.34
5.0 2687.7 Overlap Overlap 8.05 9.07 9.07
5.2 2640.7 2164.3 2633.7 7.93 9.25 7.20
5,3 2853.9 2559.2 2712.6 7.88 9.25 6.52
5.4 2322.5 1984.3 2858.0 7.92 9.38 5.92
Table 15 Percentage earryover of 2,3-DHBA, 2,5-DHBA and 3,4-DHBA after different 
numbers of washes with 50% methanol/water.
% Carryover
No of washes 3,4-DHBA 2,3-DHBA 2,5-DHBA
1 2.4 14.4 11.2
2 1.8 17.2 8.5
3 1.2 11.5 4.5
4 1.6 8.9 5.4
5 1.5 5.5 2.9
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2.8 Optimisation of SPE for 2,3-DHBA and 2,5-DHBA assay
2.8.1 Analysis of SPE eluent fractions for 2,3-DHBA and 2,5-DHBA
In the first 1.0ml of eluent collected, 85% and 88% of 2,3-DHBA and 2,5-DHBA were recovered 
respectively (% of total recoveiy), with veiy little collected in the final 4mls as shown in Fig. 12, 
p.83. To obtain a good recoveiy of 2,3-DHBA and 2,5-DHBA from the SPE process, less eluent 
could be used.
2.8.2 SPE of blank serum using the new mobile phase at pH 5.3.
Serum was extracted from a subject known not to be taking aspirin and the f- of the unknown 
peaks in blank serum, thought to be 2,3-DHBA and 2,5-DHBA, had identical t, to standard 
solutions of 2,3-DHBA and 2,5-DHBA. Although the pH of the mobile phase had changed, the 
two unknown peaks co-eluted with the 2,3-DHBA and 2,5-DHBA standards suggesting the 
presence of these compounds in non-aspirin takers.
2.8.3 Setting up a gradient to elute unwanted peaks,
4 gradient programmes were set up in order to reduce the time at which the final peak eluted. 
Chromatograms were obtained showing the elution of late eluting peaks at around 30 minutes. The 
program that allowed subsequent injections to be analysed with the shortest time between 
injections was program 3.
2.9 The effect of carryover of peaks
After injection of 2,3-DHBA, 2,5-DHBA and 3,4-DFIBA with an injection of 0.05M PICl between 
each standard, canyover existed from one sample to the next. In order to overcome this problem, 
two experiments were carried out.
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Fig. 12 Analysis of SPE eluent fractions for 2,3-DHBA and 2,5-DHBA showing peak heights 
obtained from each 0.5ml extracted.
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2.9.1 The effect o f the number o f washes o f the autosampler needle on cariTOver.
The results of the effect of canyover after injections of 2,3-DHBA, 2,5-DHBA and 3,4-DHBA 
followed by vaiying number of washes (1-5) with 50% methanol/water are shown in Table 15, 
p.81. We can see that although results do improve with the number of washes, there is still some 
canyover of each analyte after the maximum number of washes.
2.9.2 The investigation of different wash solutions.
The effect of four different wash solutions on canyover of 2,3-DHBA, 2,5-DHBA and 3,4-DHBA 
were investigated with the results shown in Table 16, p.84. We can see that 0.2M HCl eliminates 
canyover of 2,3-DHBA and 2,5-DHBA from standard solutions but that a small amount of 3,4- 
DHBA still remains.
Table 16 Percentage canyover of 2,3-DHBA, 2,5-DHBA and 3,4-DHBA using different wash 
solutions.
Wash solution ( 5 
washes between inj.)
% Canyover
3,4-DHBA 2,3-DHBA 2,5-DHBA
50%MeOH:0.05MHCl 1.0 6.6 3.8
0.05mM HCl 0.7 4.5 2.5
0.1 OmM HCl 0.8 2.5 0.0
0.20mM HCl 1.0 0.0 0.0
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DISCUSSION
1.1 Ontimisation of chromatographic conditions for the SA assay.
The optimisation of the chromatographic conditions in the development of an HPLC method is 
essential in order to be able to produce a robust and reliable method. Some of the factors that were 
taken into account when developing the SA method are discussed below.
The first step in the development of the method for SA was to find a suitable mobile phase. An 
ideal mobile phase could be defined as one that allows good resolution of the analytes of interest 
from any interference after extraction and which results in a short elution time leading to a fast 
throughput of samples. The mobile phase used for the identification of SA in our developed 
method was similar to that used by Grootveld and Halliwell for the detection of 2,3-DHBA and
2,5-DHBA, structurally similar compounds to SA (See Fig.3, p. 15 for 2,3-DHBA and 2,5-DHBA 
structures).^'^
One way in which to elute peaks more quickly under reversed phase conditions is to change the 
polarity of the mobile phase. In this case the methanol content of the mobile phase was increased 
and we can see from Table 1, p.52 that as you increase the organic content of the mobile phase 
then the peaks elute more quickly. The mobile phase comprising of a methanolic concentration of 
28.6%(v/v) results in a t, of 5.82 minutes for SA and good resolution from any possible 
interference after extraction from serum (Fig 5b, p.54). Evans et al investigated the oxidation of 
SA at a glassy carbon planar electrode and showed that the electrode reaction was found to be 
dependent on the pH and the ionic strength of the buffer content of the mobile phase.'*  ^Further 
work showed that a maximal electrochemical signal was obtained with a supporting electrolyte 
concentration of 0.06mol dnf^ acetate buffer in 35% methanol (pH 5.0). The magnitude of the 
response was observed to inerease by about 10% when the methanol concentration was decreased 
from 35% to 8%. However, this was thought to be due to solubility of SA or possibly changes in 
conductivity of the electrolyte.
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Chromatographic run times are dependent on the mobile phase content and determined by the 
elution time of analytes, IS and of any background peaks which might interfere with subsequent 
injections, these latter being a particular problem at low analyte concentrations. At low SA 
concentrations (0.1-50|uM), the cleaner extracts obtained using SPE allowed a run time of 35 
minutes to be achieved. Evans et al found it necessaiy to reduce the methanol content of the 
mobile phase from 35% to 8% to separate SA from interfering p e a k s .A s  a result of reducing the 
organic content of the mobile phase, they obtained a tr of 11 minutes for SA suggesting a longer 
run time for their method, however, no data was provided on run time in their paper. Vree et al, 
however, reported a tr of 32 minutes for SA in their non-extraction assay but used a gradient 
method to elute unwanted peaks, thereby allowing a quicker throughput of sam ples .A further 5 
minutes was required to elute late interfering peaks, and in addition, time would be required for 
equilibration of the HPLC system to the initial mobile phase conditions. The time between each 
injection would then be approximately 50 minutes, almost twice as long as our current method. 
Once a suitable mobile phase had been chosen which provided good resolution of the SA peak and 
satisfactoiy run times, a suitable extraction technique for extracting SA from serum had to be 
developed. In the literature either direct injection or liquid-liquid extraction techniques are 
described but it was thought that SPE may be a better option in order to obtain “cleaner” 
chromatograms thereby permitting shorter elution times and a greater potential choice of IS. 
Initially HAX columns (anion exchange columns) were used since it was believed that SA could 
undergo ionic interactions under suitable pH conditions with an ionic exchange column. The SPE 
procedure that was followed suggested adjusting the pH of the serum to 2.5 using l.OM HCl. The 
pKa value of the carboxyl ic acid group of SA is 2.98. According to the acidic dissociation 
constant, less than half of the carboxylic acid groups of SA will be negatively charged at a pH of 
2.5, therefore it would be expected that the extraction recoveries achieved at this pH would be less 
than 50% if an anion exchange column was used. Interestingly, the extraction recoveries using 
these conditions were of the order of 85%, not a theoretically achievable value based on anion 
exchange alone.
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The manufacturer of the columns (Jones chromatography) was contacted and they explained that 
the packing material contained not only anion exchange material but also some non-polar material. 
Other interactions between the sorbent packing material and the analyte were thought to be taking 
place. The structure of SA (Fig lb, p .l) would suggest that non-polar interactions could take place 
between the SPE column and the four ring carbons of the benzene ring which have no substituents 
attached.
Stewart et al reported that Cjs columns (Bond-Elut octadecylsilane) produced recoveries of 91.8% 
for SA in acidified plasma but that other columns, including anion exchange columns, produced 
recoveries consistently below 15% from acidified plasma.^^ Moore and Tebbett, looking at the 
rapid extraction of anti-inflammatoiy drugs in whole blood for HPLC analysis, reported that Cg 
columns produced the best recoveries (85% for SA at 15ug/ml, lOOpM).^^
The two references suggest that acidified plasma will undergo non-polar interactions with high 
extraction recoveries. Another plausible explanation is that carboxylic acid and hydroxyl 
functional groups may interact with free silanol groups on the surface of the sorbent via hydrogen 
bonds. It is likely that a combination of these interactions is responsible for the high extraction 
recoveries obtained during this work.
Before it was discovered that the SPE columns contained non-polar packing material, optimisation 
of the extraction procedure was investigated by varying serum pH between 2.0 and 2.7, extracting 
each sample and monitoring extraction recoveries. During routine experiments involving 
extraction, serum pH varied from experiment to experiment and sample to sample since additions 
of small amounts of FICl caused variable pH values. On assessing what effect this had on 
extraction efficiencies, it was found to have no significant effect on the SA recoveries 
(Table 3, p.55). This finding supports the hypothesis that non-polar interactions are taking place 
since pH does not seem to have any significant effect on the extraction recoveries.
When validating methods which involve extraction procedures, it is essential that a suitable IS can 
be found. One of the advantages of using SPE when looking for an IS is that cleaner extracts
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were produced, resulting in fewer interfering peaks therefore more baseline where there was no
interference present for an IS to elute. This enabled an IS to be chosen more easily.
Interfering peaks were a problem for Grootveld et al, including those due to catecholamine peaks 
(Fig.4a, p.21),^° whilst Vree et al published a cliromatogram containing many peaks in the first 20 
minutes where it would not be possible for an IS to elute due to interference.^^ Evans et al 
published chromatograms which were erowded with peaks and they were unable to find a suitable
IS."^ ’^ Shell et al also published chromatograms which were very crowded and although an IS was 
chosen, complete resolution of the IS and interfering peaks was not achieved.
After looking at a number of compounds (Table 4, p.56) a suitable IS was found; 4-MeSA. 2,5- 
DHPAAGL was investigated as a possible IS since it was well resolved from any interference and 
had similar voltammetric behaviour to SA. However, when blank serum was spiked with 2,5- 
DHFAAGL and extracted, no peak corresponding to 2,5-DHPAAGL was found to be present in 
the chromatogram of the extracted sample. It was likely that an intermediate reaction had taken 
place causing breakdown of the lactone during the extraction process. It is known that acyclic 
esters and cyclic esters (lactones) undergo hydrolysis at acid pH to yield carboxylic acids and 
alcohols and this may have been the fate of the 2,5-DHPAAGL.
4-MeSA was found to elute free from any interference from extracted serum with a f  of 12 
minutes (Fig.5b, p.54). 4-MeSA had a similar voltammetric profile to that of SA (Fig.6a&b, p.58), 
extracted with good efficiency and standard curves produced correlation coefficients of typically 
greater than 0.997 using 4-MeSA in peak height ratio calculations (Fig.7, p.60). 4-MeSA was 
found to be linear over a concentration range (0.1-50|aM) equivalent to that of the SA standard 
cuiwe range. The difficulty in finding a suitable IS is clearly shown in published methods 
where no IS was used by Evans et al"^  ^and Reidl and although a large number of IS (35) were 
examined by Siehert and Bochner, none were found to be suitable.^^ Shen et al claimed to have 
found a suitable IS in H7-hydroxybenzoic acid, but chromatograms in their paper are crowded, with 
the SA and IS peaks on a steep decline and not completely resolved.'^^ Mays et al^^ and
Eliott Cham et used mephenytoiii and o-methoxybenzoic acid respectively as their IS with 
good resolution of the SA from the IS, but these methods lack the required sensitivity to detect low 
levels of SA produced after oral administration of low-dose aspirin.
Very few methods, with the exception of Evans et use BCD. The method described in this 
thesis permits concentrations of SA standards equivalent to those of patients taking low-dose 
aspirin (0.1~50p,M) to be detected.
Precision was thought to be an important factor since veiy low analyte concentrations were to be 
quantified. Air bubbles were a common source of problems even when the mobile phase was 
continually sparged with helium. An on-line degassing unit was acquired in order to overcome this 
difficulty, thereby substantially reducing the amount of dissolved air. Air bubbles frequently 
congregated in the reference electrode (part of the main cell component), causing poor electrical 
conductance in the salt bridge (3.0M KCi). This resulted in noisy baselines and poor detector 
response. The setting up of the reference electrode was a process of trial and error but with 
experience using this equipment, these problems with the air bubbles became less of an issue.
After setting up the main cell of the detector and allowing equilibration time, analysis took place 
with further problems arismg from fouling of the glassy carbon electrode. This caused increased 
background noise and reduced sensitivity. HPLC grade water and smaller filter pore size were 
introduced for removing dissolved gases. The pore size of the filters were changed from 0.45 
micron to 0.22 micron to minimise the amount of dissolved air. The supplier of the ECD informed 
us that the cartridges used for filtering the water release tertiaiy amines and these amines have the 
capability of fouling the carbon electrode when oxidised. To clean the glassy carbon surface after 
light fouling, a piece of tissue saturated with ethanol/methanol was used to wipe the surface clean. 
If there were deposits engrained on the surface and the surface was not clear after light cleaning 
then it was necessaiy for diamond sluriy to be applied to a glass-backed polishing mat and the 
surface polished in this manner. Thus, as a result of the careful set up of the ECD, greater 
sensitivity was achieved compared with previously published work (Table 17, p.90).
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Table 17 List of limit of detection (LOD) values from a selection of recently published work.
Author Biological medium Limit o f detection (LOD)
Current method serum 15pmol/ml
Eliott Cham et plasma 22pmoVml
Siebert and Bochner plasma 11 Ipmol/ml
Shen et plasma 720pmol/ml
Evans et serum 1.5nmol/ml
Vree et plasma 1.5nmol/ml
Reidl plasma 1.5nmol/ml
mine 750pmol/ml
Table 18 List of extraction efficiencies from a selection of recently published work.
Author Biological medimn Extraction efficiency (%)
Elliot Cham et plasma 99-102
Shen et a l ‘^^ plasma 92-100
Mays et urine 98
plasma 85
Current method serum 85
Reidl plasma 89
Siebert and Bochner plasma 70
Evans et serum 60
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Fig. 13 Comparison of voltammograms of extracted blank serum and standard SA
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The combination of SPE (cleaner extracts) and sensitive detection (ECD) allowed much lower 
concentrations of SA to be detected. At maximum sensitivity a peak occurred at the same T as SA 
in the "blank" sera. This could have been due to several factors, including interference, or that 
salicylate was already present in human serum at veiy low concentrations. Voltammograms of 
extracted serum and standard SA were plotted from the data, which showed that they had a similar 
voltammetric profile (Fig 13, p.91). Results indicated (Table 2, p.52) that the peaks in human 
serum were probably due to SA (canyover from previous injections was carefully excluded). It 
was found that all “blank” sera obtained from normal subjects not consuming aspirin or other 
salicylate drugs contained SA at concentrations less than 75pmol/ml,
Swain et al reported information on food products which are known to contain SA, and this may 
be a source of the veiy low levels found in blank sera.*’^  Hence, with veiy low dose aspirin 
treatment, the serum SA concentration which is measured may not originate solely from the 
aspirin. This is now an area of salicylate research that is being followed up in the labs at the 
Crichton Hospital. Published methods that have sufficient sensitivity to detect low SA levels have 
also shown small interfering peaks at the same tr as SA in blank plasma or serum. Siebert and 
Bochner published a paper that showed a chromatogram that had such an interference, although 
they did not discuss the origin of this in their paper.^^
92
1.2 Method validation of SA assay
After optimisation of the chromatographic conditions had been successfully completed, work had 
to be carried out to validate the method. A method can only be considered to be validated after 
certain criteria have been met.
Comparison of extraction efficiencies with other published methods indicates that the method 
described in this thesis provides satisfactory extraction efficiency (Table 18, p.90).
Great care had to be taken when adding methanol in the initial preparation of the SPE column to 
prevent disturbance of the sorbent materials. If the sorbent bed was disturbed poorer extraction 
efficiencies resulted. Methanol was added dropwise to the columns and allowed to seep through 
under gravity in to prevent this from happening.
The SA peak response was linear over a concentration range of 0. l-50j_iM extracted from 0.5ml of 
sera (Fig.7, p.60). Since sera was to be used in the preparation of calibration curves, it was decided 
that it would be of benefit if a source of sera other than human sera could be found. New born calf 
sera was extracted but unknown interfering peaks were present which co-eluted with the SA and 
IS peak. Sera from patients was pooled and extracted to ensure that there was no significant 
interfering peaks present with the same tr as SA or IS. These non-interfering pooled samples were 
stored in 3ml aliquots at -30°C until required for use in the preparation of calibration curves to 
provide linearity data.
Experiments were set up involving both intra- and inter-assay precision. Precision is the closeness 
of agreement between independent test results obtained under prescribed conditions. Each day an 
assay was carried out, a blank serum sample was extracted to ensure no interfering peaks were 
present at the f o f  the SA or the IS (selectivity). Precision is an essential element in validating an 
analytical method to show that the method is not susceptible to change both from day to day and 
within day variations. Results from our work indicated that both inter and inti'a-assay precision 
were adequate with the greatest variation being shown, not surprisingly, at the lowest level 
concentration (Table 6, p.62). The level of accuracy of the method was calculated using the data
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obtained from tiie precision work and the results obtained showed the method to be satisfactorily 
accurate. In addition, stability experiments were carried out over a period of 13 days under 
different conditions. Instability was not found to be a problem.
The sensitivity, reproducibility, precision and accuracy as demonstrated in the results section 
indicates that this assay of SA could be applied to research studies involving patients with 
different pathologies taking low dose aspirin. The analysis of serum specimens obtained from 
diabetic patients confirmed this.
2.1 Optimisation of chromatographic and extraction conditions for 2,3-DHBA and 2,5- 
DHBA assay.
Optimisation of the chromatographic and extraction conditions for 2,3-DHBA and 2,5-DHBA was 
carried out in a similar manner to that for SA.
A suitable mobile phase had to be chosen that would provide good resolution of 2,3-DHBA, 2,5- 
DHBA and the chosen IS. As a starting point in finding a suitable mobile phase, the literature was 
reviewed and the clu'omatographic conditions of other research groups considered. Floyd et al 
used a mobile phase consisting of 3OmM acetic acid and 3OmM citric acid. The mobile phase was 
then titrated to a pH of 3.0 with solid sodium hydroxide followed by sodium acetate to a final pFI 
of 3.6 and this was continually sparged using nitrogen gas.^ ® The resulting published 
cliromatogram shows insufficient resolution of the 2,3-DHBA and 2,5-DHBA peaks, therefore, 
this mobile phase was not considered. Moreover this research employed standard solutions only, 
such that interferences in serum from an extraction process were not taken into account.
Of work that has been carried out on serum, Grootveld et al used a mobile phase consisting of 
3OmM sodium citrate/27mM acetate buffer at a pH of 4.75.^° They stated that 2,5-DHBA was 
found to elute very close to their IS, 3,4-DHBA. However, the chromatogiaphy in general was 
unsatisfactory and contained significant interference.
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Udassin et and Das et employed the same mobile phase used by Floyd et but also 
added 0.2g/l sodium azide. However, the chromatography produced from extracted body fluids 
was veiy poor. Ghiselli et used a similar mobile phase to Grootveld and Halliwell^° with the 
only difference being the methanolic concentration. Poor resolution of the 2,3-DHBA and 2,5- 
DHBA peaks was obtained.
The mobile phase that was considered in this work was 100% 3OmM tri-sodium eitrate buffer, 
with the pH adjusted to 4.75 using glaeial acetic acid. The pH of the mobile phase was later 
changed to pH 5.3 because of relatively poor resolution of the 2,3-DHBA from the 2,5-DHBA 
when a new, “identical” analytical column was purchased. This was probably due to column to 
column variation which occurs as a result of slight differences in the behaviour of different 
batches of the same packing material resulting in differences in the column chemistiy.
The pH was altered to eliminate any future problems with resolution and provide a more robust 
method. However, some development work was carried out using the initial mobile phase 
conditions at a pH of 4.75 and is described below.
Voltammograms (Fig.9a & b, p.67) of 2,3-DHBA and 2,5-DHBA were drawn and it was shown 
that the applied potential across the glassy carbon electrode whieh produced the maximum current 
response was around 0.70V. This applied potential was similar to that found in published work. I
Floyd et al applied a potential of 0.80V,^® Grootveld et al a potential of between 0.60-0.68V,^° Das 
et al a potential of 0.60V and Ghiselli et al a potential of 0.76V.^^ Hence, the published values of 
applied potential varies from 0.60-0.80V, agree with the value of 0.70V used in our current 
method. The variability in Eox applied by the various research groups could be caused by a number 
of factors. As shown by Evans et al, mobile phase content can affect the voltammetric behaviour 
of SA and the geometty of the electrode and the electrode material may also have an effect.'*^
Extracts of blank sera from subjects not consuming aspirin showed the presence of small 
interfering peaks at the same tp as 2,3-DHBA and 2,5-DHBA. It was thought that 2,5-DHBA
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could be present since work earried out by Ingelman-Sundberg et al on microsomal fractions from 
mammals treated with indueers of cytochrome P-450 indicated that salicylate was metabolised to
2,5-DHBA/^ It was also shown that under the same conditions, although 2,5-DHBA was found 
no 2,3-DHBA was formed. To help characterise the unknown peaks with tr values similar to 2,3- 
DHBA and 2,5-DHBA, the ratios of blank unknown peaks and standard solutions of 2,3-DHBA 
and 2,5-DHBA were calculated at different Eox values and the values compared. The measured 
ratios were similar (Table 10, p.68), indicating that it was likely that 2,3-DHBA and 2,5-DHBA 
were present in blank sera. Further work carried out in this laboratory supports this view (C. 
Blacklock, personal communication), with the unknown peaks having similar tr values to 2,3- 
DHBA and 2,5-DHBA using three different mobile phase conditions.
When eariying out the development of the SA method it was discovered that small amounts of SA 
were present in extracted blank sera raising the possibility that 2,3-DITBA is generated by 
hydroxyl free radical attack on any SA present. SA is known to occur in many different foodstuffs 
and wines.^^
A letter in the Lancet by Muller and Fugelsang indicated that 2,3-DHBA, 2,5-DHBA and SA were 
present in a selection of Californian wines, both red and white.*"^  They stated that more SA, 2,3- 
DHBA and 2,5-DHBA are present in red wines than in white but that levels in white wine of SA,
2,3-DHBA and 2,5-DHBA were still significant.
Extraction conditions for 2,3-DHBA and 2,5-DHBA were identical to those described for the SA 
method but the selection of a suitable IS again proved difficult. 3,4-DHPAA seemed a suitable 
candidate since it had similar voltammetric behaviour to 2,3-DHBA and 2,5-DHBA. However, 
when 3,4-DHPAA was prepared in solution as an aqueous mixture with 2,3-DFIBA and 2,5- 
DHBA, the 3,4-DHPAA peak heights dropped markedly when compared to when it was injected 
individually (Table 12, p.70). A further 6 compounds were examined with only two oxidising at 
the same applied Eqx as 2,3-DHBA and 2,5-DHBA, These were 3,4-DHBA and gallic acid (3,4,5- 
trihydroxybenzoic acid). 3,4-DHBA was chosen beeause of its structural similarity to 2,3-DHBA
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and 2,5-DHBA and it was thought that it would have similar physicochemical behaviour for 
extraction purposes.
It was at this stage of the development of the method that resolution of the 2,3-DHBA and 2,5- 
DHBA deteriorated due to the introduetion of a new column even though clu'omatographic 
conditions were unchanged. The resolution of the 2,3-DHBA, 2,5-DHBA and 3,4-DHBA analytes 
at a concentration thought to approximate the levels of those taking low dose aspirin was poor 
with saddling of the peaks introduced. In order to try and improve resolution, two components of 
the mobile phase were looked at which were believed might help to resolve this problem.
Firstly, small amounts of organic solvent were added to the mobile phase to ti-y and separate the 
peaks of interest. 4.75% v/v of acetonitrile was added to the mobile phase buffer, but the three 
analyte peaks eluted more quickly with the 2,3-DHBA and 2,5-DHBA peaks viitually co-eluting, 
and the 3,4-DHBA peak poorly resolved from these co-eluting peaks (Fig. 10a, p.73). 1.5% v/v of 
methanol was added to the buffer, but increased saddling of the 2,3-DITBA and 2,5-DHBA peaks 
(Fig. 10b, p.74) was observed. Addition of organic solvents clearly did not improve the resolution 
and so the pH of the mobile phase was investigated as a means to improve resolution.
A range of mobile phases with different pH values were prepared with the pH ranging from 4.75 - 
5.4, Standard solutions of 2,3-DFIBA, 2,5-DHBA and IS were cliromatographed. As the pH of the 
mobile phase increased, the f  gap of the 2,3-DHBA and 2,5-DHBA peaks increased, and 
simultaneously, the 3,4-DHBA peak eluted more quickly at a rate of approximately 0.80 minutes 
per 0.1 pH unit change with respect to the 2,3-DHBA and 2,5-DHBA peaks (Table 14, p.81 & 
Fig.l la-e, p.75-79). When the pH of the mobile phase was 5.3, resolution of the 3 analytes was 
improved with detector response for 2,3-DHBA and 2,5-DHBA also improved. Poor resolution of 
the 2,3-DFIBA and 2,5-DHBA is a problem observed in previously published methods. None of 
the published methods to date show satisfactoi-y resolution of these two analytes, whether a 
standard solution or extracted plasma or sera are used. Floyd et al state that the 2,3-DHBA and
2,5-DHBA compounds have similar f , but are separated enough from each other to differentiate
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between them/^ This suggests that baseline resolution has not been achieved. They examined 
different mobile phases and found the most suitable to contain 3 OmM acetic acid, 3OmM citric 
acid, with the pH altered to 3.0 with solid sodium hydroxide and then with sodium acetate to a 
final pH of 3.6. Method development carried out by this group was done using aqueous solutions, 
thereby avoiding the need to consider potential interfering analytes present in body fluids. 
Grootveld et «/used three separate methods employing different ehromatographic conditions in 
each.^° In "method A" (specific for 2,3-DHBA and 2,5-DHBA), diethylether was used as the 
extracting solvent and the mobile phase consisted of 100% 3OmM sodium eitrate/27.7mM acetate 
buffer pH 4.75. Chromatograms show that 2,3-DHBA and their IS, 3,4-DHBA, are well resolved 
but the paper states that 2,5-DHBA has a similar t, to 3,4-DHBA. This suggests that eo-elution is a 
problem with the IS but no chromatogram is provided to show this. A chromatogram of an extract 
from a healthy control not consuming aspirin is provided with a large peak, which may be 
equivalent to 2,5-DHBA, shown to elute at a similar f  to 3,4-DHBA. Extracts from plasma and 
knee joint synovial fluid showed 2,3-DHBA poorly resolved from unknown peaks, thought to be 
catecholamines (Fig.4, p.21). Das et used the same method as Floyd^^ but the 2,3-DHBA and
2,5-DFIBA peaks look as if there are other peaks co-eluting with them. Ghiselli^^ used a similar 
method to Grootveld and Halliwell^*’ but resolution of the 2,3-DHBA and 2,5-DHBA was poor. 
The chromatography and resolution achieved in our current method is a significant improvement 
over those methods previously published. SPE of blank sera using the new mobile phase 
conditions still produced two peaks at the same f  as 2,3-DHBA and 2,5-DHBA.
Now that the chromatographic conditions were optimised as far as the resolution of the 2,3- 
DHBA, 2,5-DHBA and IS were concerned, a further problem arose. Data from an injection from 
an extracted sample was acquired overnight. The chromatography was looked at in the morning 
and it was observed that a broad peak eluted from the column with a tr of 120 minutes (2hrs). This 
resulted in canyover of this late eluting peak into subsequent injections. In order to prevent this
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carryover and to prevent such potentially long run times, a gradient method was introduced. The 
two solutions acting as mobile phases in the giadient set up were the normal mobile phase (pH 
adjusted to 5.3) (A) and 28.6%(v/v) 3OmM tri-sodium citrate with the pH adjusted to 5,3 (B). 
Methanol had been used for mobile phase (B) but it was discovered that methanol on its own 
caused uncontrollable baseline drift, probably due to leakage of small amounts of methanol into 
the salt bridge. Four different programs were set up and extracts injected onto the column. 
Optimum gradient conditions were attained using Program 3.
Further optimisation of the extraction procedure took place to see if the amount of eluent in the 
final stage of the SPE procedure could be reduced from 5mis thus providing a more concentrated 
extract. Fractions of eluent were collected and individually injected to show that 85% and 88% of
2,3-DHBA and 2,5-DHBA were recovered respectively from the first 1ml collected (% of total 
reeoveiy), with veiy little collected in the final 4mls.
Finally, before the method could be validated, canyover of analytes between injections had to be 
resolved. Since such low concentrations of analytes were required to be detected, any degree of 
carryover could contribute significantly to the signal of a subsequent injection. To investigate this 
problem, two experiments were carried out, the first being to increase the number of flushes 
between injections from 1 to 5. A small percentage of canyover still existed even after five washes 
(Table 15, p.81), with the 3,4-DHBA canyover being the most significant (5.5%). Secondly, 
different flush solvents were prepared and showed that 0.2M HCl removed all the 2,3-DITBA and
2,5-DFIBA and only left 1.0% of 3,4-DHBA (Table 16, p.84).
The measurement of 2,3-DHBA and 2,5-DTTBA has been investigated by few research workers, 
but those methods published use ECD. Clnomatographie and extraction conditions were 
developed, employing similar conditions to those used for the determination of SA. The applied 
Eox and the mobile phase pH was changed to 0.70V and pH 5.3 respectively. In addition, the 
isocratic conditions were replaced by a gradient method to elute a late unwanted peak.
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The development work carried out in optimising both the chromatographic and extraction 
conditions has significantly improved this method over anything that is currently available in 
other published methods for measuring levels of 2,3-DHBA and 2,5-DHBA in subjects consuming 
low doses of aspirin.
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FUTURE WORK
1. To complete “validation” of the assay for serum SA.
2. To cany out pharmacokinetic studies to determine the rate of formation of SA in serum after 
administration of different doses of ASA (low to high dose). This information would 
determine the time at which blood samples could be taken to give maximum concentrations of 
SA. By eariying out studies at different doses, this would also allow monitoring of 2,3-DHBA, 
ensuring that complete quenching had taken place. The concentration of hydroxyl free radicals 
in subjects could then be monitored. In order to get a meaningful measure of hydroxyl radical 
production it would also be necessaiy to cany out analysis on “blank” sera to assess baseline 
concentrations of 2,3-DHBA.
3. To cany out studies on groups of patients with different pathologies where hydroxyl free 
radical damage is suspected e.g. schizophrenics, diabetics and patients who suffer from 
coronaiy heart disease. By measuring concentrations of SA and 2,3-DHBA in these subjects it 
would allow estimation of the relative concentrations of free hydroxyl radicals being 
quenched by the SA to form 2,3-DHBA.
4. To compare results from differing assays estimating free radical activity.
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